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Abstract 
In the early development of brain, there is an important period called the 
synaptogenesis period (also known as the brain growth-spurt period) which occurs in 
different mammalian species at different times relative to birth. In rodents, it begins 
a day or two before birth and ends 2 weeks after birth, whereas in humans it starts 
at the beginning of the third trimester and ends several years after birth.  This is a 
critical period during neural development as neurons are establishing 
communications with their environment and other neurons to ensure that they 
develop and function appropriately; disruption at this stage by toxic agents including 
anaesthetic agents may compromise the normal neuronal development of the 
central nervous system.  
 
During the course of my PhD study, I found that inhalational agents isoflurane (ISO) 
alone or in combination with nitrous oxide (N2O) caused a wide spread 
neurodegeneration in the brain including the cingulated cortex, hippocampus, 
substantia nigra and basal forebrain in postnatal day 7 Sprague-Dawley rat pups. In 
those brain regions, the cells involved included glutamatergic, GABAergic and 
dopaminergic neurons. However, the cholinergic neurons in the basal forebrain were 
spared from anaesthesia-induced neuroapoptosis. My studies also showed that the 
neurodegeneration was not only confined to the higher centres, but was also 
observed in the spinal cord. These data indicated that the anaesthetics studied acted 
at molecular level and induced neuronal apoptosis by activating the intrinsic 
apoptotic pathway.  
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It has been well documented that preconditioning with hypoxia or other 
interventions including pharmacological agents can protect against subsequent brain 
injury induced by hypoxia/ischemia. However, my data showed that hypoxic 
preconditioning exacerbated N2O+ISO-induced neonatal neurodegeneration, while 
xenon preconditioning protected against anaesthetics-induced neuroapoptosis and 
subsequent neurocognitve impairment.  
 
Most studies in this field including my own study described above are more relevant 
to the clinical situation where neonates are managed in the critical care unit, i.e. in 
the absence of surgery. For this reason, I implemented another experimental setting 
to mimic the clinical situation in the operating room where neonates receiving 
anaesthetic drugs are also subjected to nociceptive surgical stimuli. Therefore, in 
another experiment, rat pups in addition to receiving anaesthetic drugs were also 
subjected to standardised nociceptive stimuli. The results suggested that nociceptive 
stimuli enhanced neuronal apoptosis induced by anaesthetic drugs in the brain and 
the spinal cord and consequently impaired neurological function.  
 
Were the data reported in my thesis to be extrapolated to the clinical setting, it 
would have very important implications for the clinical management of paediatric 
population receiving general anaesthesia.   
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ABBREVIATIONS AND ACRONYMS 
AAS  antimycotic solution 
Ach  acetylcholine 
ADP adenosine diphosphate 
AMPA á-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate 
APAF -1  apoptotic protease activating factor 1 
ATP  adenosine-5'-triphosphate 
AUC  arbitrary unit 
BAX  promotes apoptosis by competing with Bcl-2 proper 
BBB  blood-brain barrier 
BCL-2  apoptosis regulator 
BDNF   brain-derived neurotrophic factor protein 
BID  BH3 interacting domain death agonist 
cAMP  cyclic adenosine monophosphate 
CCI  chronic constriction injury 
CFLIR  c-Fos-like
 
immunoreactivity 
ChAT choline acetyltransferase 
CNS central nervous system  
CREB  cAMP response element-binding protein 
DAB  3, 3’- diamino-benzidine 
ECL  enhanced chemiluminescent 
ERK   extracellular-signal-regulated kinases 
FAS  fetal alcohol syndrome  
                                                                                                                                                                             Yi Shu 
Imperial College London                                                     6                                                                                    Dec 2010   
GABA   gamma-aminobutyric acid 
GAD67  glutamic acid decarboxylase-67 
HBSS  hanks-balanced salt solution 
HIF-1á  hypoxia-inducible factor-1á   
HSG  high sucrose-glucose 
IL-beta  interleukin beta 
IR  immunoreactive 
KA  kainic acid 
LTP  long-term potentiation 
MAC        minimum alveolar concentration 
MAP  mitogen-activated protein 
N2O  nitrous oxide. 
NDS  normal donkey serum 
NGS  normal goat serum 
NMDA  N-Methyl-D-aspartate 
OGD  oxygen-glucose deprivation 
P53 tumor protein 53 
PAG  periaqueductal gray 
PBS  phosphate buffered saline 
PCD physiological cell death 
PND  post-natal day 
PT  permeability transition 
PTZ   pentylenetetrazol 
SNI  spared nerve injury 
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TBS-T  tris buffered saline 
TIAs  transient ischaemic attacks 
TNF-α tumor necrosis factor 
tPA  tissue plasminogen activator 
vGLUT1  vesicular glutamate transporter 1 
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CHAPTER 1                                           
INTRODUCTION  
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Practitioners have long held the illusory hope that the constellation of profound 
behavioural effects comprising general anaesthesia is entirely reversible and that the 
central nervous system (CNS) is returned to its pristine state once the anaesthetic 
agent is eliminated from the active site. However, there is increasing evidence to 
suggest that general anaesthetics exert long-term effects on the CNS following 
administration depending on the class of agent and the age of the exposed subject.  
 
Alcohol abuse during pregnancy can cause neurobehavioral disturbances in children 
ranging from hyperactivity and learning disabilities to depression and psychosis and 
this clinical condition is called Foetal Alcohol Syndrome (FAS). This syndrome has 
been well documented by several elegant laboratory works in rodents (Jevtovic-
Todorovic et al., 2000; Olney et al., 2004). It is thought that the brain is particularly 
sensitive to toxins including ethanol during the period of synaptogenesis, also 
known as the Brain Growth Spurt period. In rodents, synaptogenesis occurs 
predominantly as a postnatal event, extending from approximately 2 days before 
birth to 2 weeks after birth, whereas in humans, it begins during the third trimester 
of pregnancy and lasts until 2 to 3 years after birth (Dobbing and Sands, 1979; 
Dobbing and Sands, 1993). Thus, in theory, humans may be most susceptible to the 
toxicity of general anaesthesia from the pre-partum period through infancy. In 
rodents, the developing brain is particularly vulnerable to anaesthesia-induced 
neurotoxicity at 7-days-of-age and vulnerability rapidly subsides with increasing age 
(Loepke and Soriano SG, 2008). 
The targets for the behavioural properties of general anaesthetics reside within the 
central nervous system. Until relatively recently, it had been thought that general 
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anaesthetics exert a non-specific reversible effect on excitable membranes within the 
CNS which are returned to their pristine state once the anaesthetic is eliminated from 
this compartment. However, anaesthetics are now known to modulate specific 
ligand-gated ion channels, principally GABAA receptor and the NMDA subtype of the 
glutamate receptor, thereby disrupting synaptic function (Franks, 2006). The 
possibility that these synaptic actions could result in long-term consequences was 
diligently pursued by the investigators that had originally identified the deleterious 
effects of alcohol on the developing brain (Ikonomidou et al., 2000). Alcohol is similar 
to anaesthetics, both in its’ behavioural and molecular effects; it has been shown that 
post-natal exposure of rodents to standard anaesthetics produced similar 
morphologic and functional impairment to that seen with alcohol exposure producing 
the foetal alcohol syndrome (Jevtovic-Todorovic et al., 2003a). Indeed, anaesthetics 
include N-methyl-Daspartate glutamate receptor antagonists (e.g., ketamine, nitrous 
oxide) and agents with γ-aminobutyric acid A mimetic effects (e.g., pentobarbital, 
diazepam, isoflurane, halothane, propofol) alone or in combination can cause a wide 
spread neurodegeneration as seen from in vitro to in vivo settings and from rodents 
to monkeys (Jevtovic-Todorovic et al., 2003a Istaphanous GK and Loepke AW 2009). 
However, this is still a novel area of research. There are many questions that need to 
be addressed. Hence, The aims of my research work in this PhD thesis are as follows: 
1) To establish a novel strategy which can be used to study the neurodegenerative 
effects of anaesthetic drugs in the developing brain  in vitro and in vivo settings; 2) To 
answer the question of whether this neurodegeneration occurs only in the CNS in the 
brain or also occurs in the spinal cord; 3) To determine which category of neurons are 
more vulnerable to this novel anaesthesia strategy; 4) To explore any potential 
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strategies which can prevent or attenuate such neurodegeneration; 5) To see 
whether this neurodegeneration still occurs in the presence of surgical nociceptive 
stimuli as previous studies were done in its absence. 
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CHAPTER 2  
BACKGROUND 
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2.1 Foetal Alcohol Syndrome  
Foetal alcohol syndrome (FAS) refers to a constellation of physical abnormalities, 
most obvious in the features of the face and in the reduced size of the newborn, and 
problems of behaviour and cognition, in children born to mothers who drank heavily 
during pregnancy (Clarren and Smith, 1978).  Rates of FAS in most studies are 
similar—in the order of 0.5 to 3 cases per 1,000 births.  
 
The defects of FAS may or may not be apparent or easily diagnosed at birth.  
Although the manifestations of the damage might change with age, FAS never 
completely disappears and, as with many developmental disabilities, there is no cure, 
but there may be some amelioration in some individuals (Forrest and du Florey, 
1991). FAS do not refer to signs of acute alcohol exposure or withdrawal at birth. 
Newborns can have blood alcohol levels high enough to affect acutely their central 
nervous system function and not have FAS (Abel et al., 1983).  
 
Alcohol was also used as an anaesthetic drug in the last century in dental paediatric 
anaesthesia. It acts on NMDA and GABA receptors. This may be the reason 
encouraging scientists to investigate the potential neurotoxicity of anaesthetics in 
the developing brain in nowadays.  
 
Currently used anaesthetics act by modulating the activity of the gamma-amino-
butyric acid and glutamate neurotransmitter systems. It has been hypothesised that 
during synaptogenesis, neurones with N-Methyl-D-aspartate (NMDA) receptors are 
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sensitive to both over- and under-stimulation. Abnormal inhibition of neuronal 
activity, either via blockade of the NMDA glutamate receptor or by excessive 
stimulation of the GABAA receptor, triggers neuronal apoptosis. Only a transient 
disturbance lasting a few hours can trigger apoptotic neurodegeneration (Olney et 
al., 2002d). 
 
2.2 Molecular mechanism of anaesthetics 
The list of CNS transmitters is rapidly expanding. In addition to the classic 
transmitters (e.g., acetylcholine), endogenous amino acids and peptides may act as 
neurotransmitters or modulate the action of other neurotransmitters. Furthermore, 
the postsynaptic action of neurotransmitters may result in the formation of second 
messengers that mediate changes in neuronal transmission. Limited information is 
available concerning the relationship between the levels of neuroregulators in the 
CNS and the inhaled anaesthetics requirement. 
2.2.1 Acetylcholine 
Inhaled anaesthetics do not alter acetylcholine concentrations in macroscopic 
structures (e.g., cortex) of rat brain (Ngai et al., 1978) but may increase (Taguchi et 
al., 1991) or decrease (Keifer et al., 1996) acetylcholine content in specific brain 
nuclei. Inhaled agents decrease acetylcholine turnover rate, with the magnitude of 
the decrease varying with the brain region examined (Ngai et al., 1978). Synthesis of 
acetylcholine in brain is impaired by inhaled agents and is associated with an 
anaesthetics-induced inhibition of choline uptake (Griffiths et al., 1994). A 
                                                                                                                                                                             Yi Shu 
Imperial College London                                                     23                                                                                    Dec 2010   
hypothesis that depressed cholinergic neurotransmission plays a role in the 
mediation of the anaesthesia state is supported by the finding that 
intracerebroventricular injection of hemicholinium-3 (which reduces synaptic levels 
of acetylcholine) decreases isoflurane MAC* in rats (Zuker, 1991). 
2.2.2 GABA 
Although rats administered 1 to 4 percent atm halothane for 30 minutes exhibit no 
change in whole brain GABA content (Arai et al., 1990), anaesthesia may alter GABA 
levels in selected regions of the brain. Treatment of rat cerebral cortex slices with 3 
percent atm halothane inhibits the metabolism and increases the uptake or release 
of GABA (Cheng et al., 1981). If the accumulation of GABA in inhibitory neurons is 
associated with an increase in inhibitory activity, the resulting decrease in synaptic 
transmission might contribute to the anaesthetic state (Cheng et al., 1981). Findings 
consistent with this hypothesis include the production of the state of general 
anaesthesia by a GABA analogue (Cheng et al., 1985), and the ability of GABA 
antagonists to lessen the antinociceptive action of halothane in rodents (Mason et 
al., 1996). 
_________________________________________________________________ 
*MAC- Minimum alveolar concentration is defined as the concentration of the vapour in the lungs 
that is needed to prevent movement (motor response) in 50% of subjects in response to surgical (pain) 
stimulus.If MAC increasedby 10 % of its value allows anaesthetising 100% of the subjects. (Miller et 
al.,1973) 
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2.2.3 Excitatory Amino Acids 
A role for excitatory amino acids in anaesthesia is implied by the depression in 
glutamate-induced neurotransmission by inhaled anaesthetics and the decreased 
requirements of volatile anaesthetics after administering inhibitors of excitatory 
amino acid transmission (Hudspith et al., 1997). Anaesthesia does not result from a 
depletion of excitatory amino acids because rats anesthetised with halothane have 
an increased whole brain content of aspartate and glutamate (Arai et al., 1990). It 
has been suggested that the ability of enflurane to enhance glutamate release from 
synaptosomes may provide an explanation for clinically observed enflurane-induced 
convulsion (Hirose et al., 1992). 
 
NMDA (N-methyl-D-aspartic acid) is an amino acid derivative acting as a specific 
agonist at the NMDA receptor, and therefore mimics the action of the 
neurotransmitter glutamate on that receptor. In contrast to glutamate, NMDA binds 
to and regulates the NMDA receptor only, with no effect on other glutamate 
receptors. 
 
2.2.4 Calcium  
Calcium has been considered as a neuroregulator because there is evidence that 
inhaled anaesthetics alter intracellular concentrations of calcium and because 
changes in intracellular calcium may influence neuronal excitability (Kress and Tas, 
1993) (e.g., via a calcium-dependent release of neurotransmitter). Inhaled 
anaesthetics usually (Kress and Tas, 1993) but not always (Miao et al., 1995) increase 
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resting cytoplasmic calcium concentration, and it has been proposed that the 
depressant action of halothane in rat hippocampal slices involves enhancement of 
GABA-mediated inhibition through release of intraneuronal calcium (Mody et al., 
1991). In contrast, increases in intraneuronal calcium evoked by various stimuli are 
often prevented by inhaled agents. The mechanisms for the attenuation of the rise in 
calcium level by inhaled anaesthetics may depend on the anaesthetic and tissue 
examined and includes impairment of calcium influx into cells (Kress and Tas, 1993; 
Miao et al., 1995) and modulation of intracellular calcium release via action on 
inositol triphosphate-dependent pathways (Hossain et al., 1994). 
 
2.2.5 Presynaptic Action 
A presynaptic site of inhaled anaesthetic action may be implied from 
electrophysiologic recordings that compare postsynaptic potentials obtained via 
presynaptic stiumulation versus those generated by direct application of 
neurotransmitter. For example, in mouse hippocampal slices, glutamatergic 
excitatory postsynapitic currents are reduced by 50 percent by -1 MAC halothane, 
whereas halothane (even at concentrations of -5 MAC) has no effect on the currents 
induced by bath application of glutamatergic agonists. (Perouansky et al., 1995) 
 
A presynaptic site of action is also implied from studies that demonstrate an 
influence of anaesthetics on neurotransmitter release (Griffiths and Norman, 1993). 
Clinical concentrations of inhaled agents reduce depolarization-evoked release of 
norepinephrine but not acetylcholine from slices of rat cerebral cortex (Brzil et al., 
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1989). In the rat striatum, isoflurane and halothane increase spontaneous dopamine 
release (Mantz et al., 1994) but decrease nicotine-evoked release of dopamine and 
have no effect on potassium-induced GABA release (Salord et al., 1997). Inhaled 
agents do not alter basal glutamate release in guinea pig (Miao et al., 1995)  or rat 
(Schlame and Hemmings, 1995) cerebrocortical synaptosomes but are reported to 
either depress (in the guines pig) (Miao et al., 1995) or have no effect on (in the rat) 
(Schlame and Hemmings, 1995) potassium evoked glutamate release from 
synaptosomes. Thus, the ability of anaesthetics to alter neurotransmitter release 
depends on the biologic preparation examined, the method employed to evoke 
neurotransmitter release, the neurotransmitter, and the anaesthetic drug and its 
concentration. 
 
In addition to an effect on the presynaptic release of neurotransmitter, it is 
conceivable that inhaled anaesthetics may alter the duration of neurotransmitter 
action by influencing the reuptake of neurotransmitter into nerve terminals. 
Halothane and isoflurane inhibit the uptake of choline (Griffiths et al., 1994), 5-
hydroxytryptamine, and dopamine (El-Maghrabi and Eckenhoff, 1993) (but not GABA) 
(Mantz et al., 1997; Miyazaki et al., 1997) by rat brain synaptosomes in a 
concentration dependent manner. An anaesthetics-induced increase in the uptake of 
glutamate (Miyazaki et al 1997; Larsen et al., 1997) has been speculated to decrease 
excitatory transmission and contribute to action of volatile agents. 
2.2.6 Postsynaptic Action 
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There is evidence showing the postsynapitic effects of inhaled anaesthetics on both 
excitatory and inhibitory neurons. Postsynatic sites of action of anaesthetics may be 
studied by application of putative neurotransmitters thought to act directly on 
postsynaptic membrane receptors (Pocock and Richards, 1993). Depending upon the 
particular neuronal preparation and neurotransmitter studied, anaesthetics may 
depress, have little influence, or enhance the postsynaptic response. In the lamprey 
model, halothane decreases synaptic response to bath applied glutamate to the 
same extent as the decrease in the excitatory postsynaptic potential, implying a 
postsynaptic site of action (Yamamura et al., 1997). Halothane and isoflurane reduce 
the depolarizing responses to iontophoretic applications of acetylcholine or 
glutamate to dendtrites in guinea pig neocortical slices, with the acetylcholine 
response being depressed more than the glutamate response (Puil and El-Beheiry E, 
1990). In contrast, halothane and isoflurane have little or no effect on the response 
induced by iontophoretic application of GABA to perikaryons in these neocortical 
slices (Puil and El-Beheiry E, 1990). In hippocampal neurons (Zimmerman et al., 1994) 
and in neurons dissociated from the nucleus tractus solitarius of rats (Wakamori et 
al., 1991), volatile anaesthetics enhance the currents produced by application of 
GABA. 
 
A postsynaptic action is also evident from the ability of clinical concentrations of 
inhaled agents to modulate current flow through a variety of ion channels found on 
postsynaptic membranes (Harris et al., 1995). The enhancement neuromuscular 
blockade by inhaled anesthetics observed in the clinical setting probably results from 
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a reduced effectiveness of acetylcholine at postsynaptic motor endplate (Wachtel, 
1995). 
 
In summary, inhaled anesthetics act on synapses, including afferent axons at the 
nerve terminal. Inhaled agents alter axonal and synaptic transmission in isolated 
mono- and polysynaptic neuronal systems and may have both pre- and postsynaptic 
effects. Clinical concentrations of inhaled agents can depress, leave unchanged or 
enhance presynaptic neurotransmitter release and the postsynaptic response. The 
effect depends on the biologic preparation, the frequency of neuronal transmission, 
the particular neurotransmitter and the anaesthetics examined. 
 
2.3. Inhaled anaesthetics action in the CNS 
2.3.1 Brain 
Inhaled anaesthetics can act by altering neuronal activity in selected regions of the 
CNS. Because the brain stem reticular formation plays a role in altering the state of 
consciousness and alterness and in regulating motor activity, it is often suggested 
that this structure is an important site of anaesthetics action. The effect of 
anaesthesia on neuronal activity in the reticular formation is variable and can be 
increased, unchanged, or decreased, depending on the agent and the neuronal unit 
examined (Ogawa et al., 1992).  
General anaesthetics interrupt transmission in the CNS at sites other than the 
reticular formation. Clinical concentrations of inhaled agents may alter spontaneous 
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and evoked activity of mammalian cerebral cortex (Berg-Johnsen and Langmoen, 
1990) and hippocampus (Maclver and Roth, 1988). Although inhaled anaesthetics 
usually depress the excitability of brain neuron, situation can be found in which 
anesthetics enhance excitability (Maclver and Roth, 1988). In addition, inhibitory 
transmission may be influenced by volatile agents. Volatile anaesthetics may either 
enhance the amplitude and duration of inhibitory postsynaptic currents or 
selectively depress inhibitory postsynaptic potentials (Fujiwara et al., 1988). 
Neuronal pathways between various brain regions and consisting of both excitatory 
and inhibitory components may also be influenced by inhaled agents. The transfer of 
sensory information from the thalamus to certain cortical regions is thought to be 
particularly sensitive to anaesthetics (Angel, 1993). 
 
2.3.2 Spinal cord 
Both excitatory and inhibitory neurotransmission in mammalian spinal cord may be 
altered by inhaled anaesthetics (Collins et al., 1995). Anaesthetics effects depend on 
the concentration of the agent and on the particular spinal cord pathway examined. 
Inhaled anaesthetics alter responses of spinal dorsal horn to both noxious and 
nonnoxious stimuli (Collins et al., 1995).  Volatile anaesthetics also depress the F-
wave amplitude (a measure of excitability of spinal motor neurons) in rats (Rampil 
and Kings, 1996) and humans (Zhou et al., 1997). Thus, both a reduction in the 
sensory processing and an inhibition of motor neuron excitation are likely to be 
involved in anaesthetic-induced lack of movement in response to a noxious stimulus. 
In addition to a direct action on the spinal cord, inhaled agents may indirectly 
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influence activity of spinal neurons by altering the tonic input received from 
descending modulatory systems from the brain (Collins et al., 1995; Borges and 
Antognini, 1994). 
 
2.3.3 Glutamatergic and GABAergic transmission systems in CNS 
Once fully functional, a network of glutamatergic neurones forms virtually the entire 
basis for excitatory transmission in the CNS - functioning N-methyl-D-aspartate 
(NMDA) receptors are essential for survival (Forrest et al., 1994; Li et al., 1994).  The 
initial categorisation of glutamate receptors is into ionotropic ion channels (NMDA, 
AMPA and KA) and metabotropic 2nd messenger systems (Dingledine and McBain, 
1999), whilst the main ligands involved are glutamate, aspartate and glycine.  As with 
most body systems vulnerable to over-activation, the glutamatergic system is 
extensively regulated: by local glial cells (Oliet et al., 2001) and molecules such as  
glutamate, Mg
2+
, Zn
2+
, H
+
 and the essential co-agonist glycine (Danysz and Parsons, 
1998).  The NMDA receptor has been associated with cognitive impairment 
(Malhotra et al., 1996), pain (Nakata et al., 2000), drug neurotoxicity (Huber et al., 
2001), schizophrenia (Farber et al., 1995), synaptic plasticity (Kato et al., 1999; 
Philpot et al., 2001), protein synthesis (Scheetz et al., 2000) and dependency states 
(Tsai and Coyle, 1998; Tokuyama et al., 2001). 
 
Aminobutyric acid (GABA) is the principle inhibitory neurotransmitter in the CNS 
(Olsen and DeLorey, 1999).  GABAergic neurones are widespread throughout the 
nervous system, and hence any systemic disruption (e.g. anaesthesia or 
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anticonvulsive therapy) could have enormously complex ramifications (Davis and Wu, 
2001).  One irregularity in the supposition that GABA is inhibitory does exist in 
specialised electrophysiological conditions in the embryo, where GABA in fact 
becomes excitatory (Olsen and DeLorey, 1999). 
 
2.4 Neurodevelopment 
2.4.1 Normal neurodevelopment 
Normal neurodevelopment is a carefully regulated sequence of events including 
proliferation, differentiation, migration and synaptogenesis (Butler, 1999).  
Glutamate is thought to have a role in all of these processes (Ikonomidou and 
Lechoslaw, 2002), for example high concentrations of glutamate at migration target 
zones suggest a role as a neuronal chemoattractant (Behar et al., 1999) along with 
the NMDA receptor used to detect it (Komuro and Rakie, 1993).  The intriguing 
finding of specific NMDA receptor subtypes (e.g. NR2B and NR2D) in different 
anatomical regions may shed light on the precise nature of migration control (Behar 
et al., 1999).  From work by the same group, it is also apparent that different species 
employ different mediators in migration control – currently either GABA (rats) or 
glutamate (mice) (Behar et al., 2001). 
 
 
 
                                                                                                                                                                             Yi Shu 
Imperial College London                                                     32                                                                                    Dec 2010   
2.4.2 Synaptogenesis 
Synaptogenesis (the brain growth spurt) is a period of a rapid establishment of 
synapses, characterised by a high level of physiological cell death (up to 1% (Olney et 
al., 2002b)).  This includes the formation of extensive corticothalamic and 
thalamocortical projections (Molnar and Blakemore, 1995).  Despite the immense 
complexity of inter-species embryology, it has been shown that comparisons can be 
made because milestones in neurodevelopment tend to occur in the same sequence 
(Clancy et al., 2001).  This permits an extrapolation of the period of peak 
synaptogenic activity from the 7 day old rat pup (Olney, 2002a) to a 0-8 month old 
human being (Ikonomidou et al., 1999; Jevtovic-Todorovic et al., 2003a).  However, 
based on analysis of NMDA receptor subtypes, it is more probable that humans 
experience an extended period of synaptogenesis which from the beginning of the 
3rd trimester of pregnancy to several years old (Dobbing and Sands, 1979; Jevtovic-
Todorovic et al., 2003a). 
 
 Synapses are morphologically distinct sub cellular junctional structures, composed 
of a presynaptic terminal, a postsynaptic target and the synaptic cleft aligning pre- 
and post-synaptic specializations (Cowan et al, 2001; Pappas et al, 1972). The 
presynaptic terminal is characterized by a cluster of synaptic vesicles surrounding the 
electron-dense membrane specializations. The postsynaptic site contains densely 
packed ion channels and signal transduction molecules. Both the pre- and post-
synaptic specializations display variable appearances depending on the organisms 
and neuronal types. 
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Anesthetics may disrupt normal synaptic transmission by interfering with the release 
of neurotransmitter from the presynaptic nerve terminals into the synaptic cleft by 
altering the reuptake of neurotransmitter to receptor sites on the postsynaptic 
membrane, or by influencing the ionic conductance change that follows activation of 
the post-synaptic receptor by neurotransmitter. 
 
2.5 Apoptosis  
Apoptosis is a highly regulated form of cell death that was first characterised by Kerr 
(Kerr et al, 1972). It is also named as the programmed cell death and involves a 
series of biochemical events that lead to a variety of morphological changes, 
including blebbing, changes to the cell membrane such as loss of membrane 
asymmetry and attachment, cell shrinkage, nuclear fragmentation, chromatin 
condensation, and chromosomal DNA fragmentation (Bursch et al, 2000).Processes 
of disposal of cellular debris whose results do not damage the organism differentiate 
apoptosis from necrosis. 
 
Redundant or unsuccessful neurones are removed from the developing CNS by this 
process. In contrast to necrosis, which is a form of traumatic cell death that results 
from acute cellular injury, apoptosis, in general, confers advantages during an 
organism's life cycle. Between 50 billion and 70 billion cells die each day due to 
apoptosis in the average human adult. For an average child between the ages of   8 
and 14, approximately 20 billion to 30 billion cells die a day. In a year, this amounts 
to the proliferation and subsequent destruction of a mass of cells equal to an 
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individual's body weight (Werlen et al., 2003).  In addition to its importance as a 
biological phenomenon, defective apoptotic processes have been implicated in an 
extensive variety of diseases. Excessive apoptosis causes hypotrophy, such as in 
ischemic damage, whereas an insufficient amount results in uncontrolled cell 
proliferation, such as cancer (Wang et al., 1995). 
 
 2.5.1. Apoptosis in the developing nervous system 
Control of physiological cell death (PCD) in the immature CNS is currently thought to 
be governed by the neurotrophic hypothesis – whereby neurones which fail to reach 
their survival promoting synaptic targets (Sherrard and Bower, 1998) initiate a 
specialised form of cell suicide secondary to withdrawal of environmental trophic 
support (Young et al., 1999) (via both neurotrophins and electrical stimulation) 
(Brenneman et al., 1990).  Due to the complex divergent and convergent nature of 
the “survival pathway” many ligands and mechanisms are involved in maintaining 
neuronal survival. The cytosol and mitochondria of neurones field a balanced 
assortment of molecules which are either anti-apoptotic (e.g. Bcl-2 and cAMP 
response binding protein) or pro-apoptotic (e.g. Bad, Bax and the caspase family) 
which determine cell fate.  Bcl-2 and its associated peptides are thought to be 
particularly important in the developing CNS (Yuan and Yanker, 2000), as evidenced 
by the high levels of expression in the neonate and the fact that experimental over-
expression of Bcl-2 can both override lack of trophic support (Garcia et al., 1992), 
and even prevent PCD altogether (Martinou et al., 1994).  A variant of Bcl-2 (Bcl-XL) 
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may have a specialised role in maintaining developing neurones before they have 
found their synaptic targets (Motoyama et al., 1995).   
 
2.5.2 Apoptosis pathway  
Two major apoptotic pathways within this have been studied extensively: the 
intrinsic and extrinsic pathway. The intrinsic apoptotic pathway involves the down-
regulation of anti-apoptotic proteins from the Bcl-2 family (e.g Bcl- 2) and various 
changes at the level of the mitochrondria which include: an increase in 
mitochondrial permeability due to the translocation of Bax from the cytosol to the 
outer membrane of the mitochondria, release of  cytochrome c from the 
mitochondria and formation of the apoptosome complex (cytochrome c, apoptotic 
protease activating factor 1 (APAF -1) and procaspase-9) which activates caspase-9. 
Subsequently, the executioner caspases-3,-6 and -7 are activated, culminating in cell 
death (Hengartner, 2000).  
 
2.5.2.1Markers of the Common Apoptotic Pathway 
Caspase-3 is considered to be the major executioner in neuronal apoptosis (Yakovlev 
and Faden, 2004; Yakovlev et al., 2001) and caspase-3 gene activity and protein is 
down regulated during brain development, which parallels the repressed apoptotic 
potential in the mature brain (Yakovlev et al., 2001). Hence, in addition to 
anaesthetics enhancing apoptotic neurodegeneration by disrupting physiological 
synaptic activity, which in turn may reduce neurotrophin-initiated survival signals, 
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the neurons in neonatal (in comparison to adult) rodents may be more vulnerable to 
death due to relative up-regulation of vital components of the apoptotic machinery 
(e.g.caspase-3 activity). 
 
2.5.2.2 Markers of the intrinsic apoptotic pathway 
The release of cytochrome c from the mitochondria into the cytosol is one of the 
principal components of intrinsic pathway activation. Once released, cytochrome c 
binds to Apaf-1 and activates the apoptosome. However, cytochrome c translocation 
does not necessarily determine cell fate, since activation of the apoptosome is also 
regulated by other factors (Yakovlev and Faden, 2004; Cozzolino et al., 2004). 
 
2.5.2.3 Markers of the extrinsic apoptotic pathway 
A representative marker of extrinsic pathway involvement is the activation of 
caspase-8.  
The probability of extrinsic pathway involvement is in line with recent findings 
suggesting that the anaesthetic cocktail of isoflurane, N2O and midazolam induces 
neuronal death in the developing rat brain by both apoptotic pathways (Yon et al., 
2005). In that setting, the intrinsic pathway was involved within 2 hours of 
anaesthetic exposure, whereas 4 hours was needed to activate the extrinsic pathway.  
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2.6 Types of neurodegeneration 
2.6.1 Excitotoxic neurodegneratione 
The term ‘excitotoxicity’ was coined to describe the neuronal toxicity of high 
glutamate concentrations at the NMDA receptor (Olney, 1969).  Following an initial 
insult (be it trauma) (Pohl et al., 1999), hypoglycaemia (Frankiewicz et al., 2000), and 
ischaemia (Martin et al., 1998), it is thought that neurones switch to less efficient 
anaerobic respiration.  The ensuing lack of ATP deranges ion pump function – 
specifically resulting in reversal of the pumps designed to clear glutamate from the 
synapse (hence producing high synaptic glutamate concentrations) (Jevtovic-
Todorovic and Olney, 2003b).  This is the mechanism by which neurones can be 
damaged long after the insult has subsided.    Specific isoforms of protein kinase C 
have been shown to modulate this process (Wagney et al., 2001) - this is almost 
certainly linked to the NMDA receptor’s ability to regulate intracellular Ca
2+
 
accumulation (Kubo et al., 2001).  At the genetic level, high levels of glutamate 
stimulation upregulate genes connected to convulsion and ischaemia (e.g. zif/268 
and c-jun) (Beas-Zárate et al., 2001). 
 
2.6.2 Neurotoxic neurodegeneration 
Assessment of the potential neuroprotective effect of NMDA receptor blockade in 
adult rats showed that excitotoxic damage could be reduced by agents such as 
MK801 (a powerful experimental NMDA receptor antagonist).  However, the very 
same experiments (Pohl et al., 1999) highlighted a major predicament with use of 
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MK801.  It was found that this drug caused cells of the posterior cingulate and 
retrosplenial cortices to acutely degenerate.  Subsequently, both N2O (Jevtovic-
Todorovic et al., 1998) and ketamine (Nagata et al., 2001) have been shown to have 
this undesirable property.  It was hypothesised that in this specific area of the brain 
glutamate is in fact inhibitory – both by regulation of inhibitory tone of excitatory 
inputs and local autoregulation by GABAergic neurones (Jevtovic-Todorovic and 
Olney, 2003).  In terms of CNS function, this neurotoxicity disrupts the extended 
hippocampal circuit of memory (of which the PC/RSC is a component) (Aggleton and 
Brown, 1999), produces the psychomimetic side effects seen with clinical use of 
NMDA receptor antagonists (Farber et al., 1995), and may be a predisposing factor 
to adult schizophrenia (Malhotra et al., 1996; Newcomer and Krystal, 2001).   
 
 
2.6.3 Neurodegeneration in neonates 
In 1999, data were published stating that use of NMDA receptor antagonists in 
neonatal rats produced specific patterns of neurodegeneration (distinct from glial 
cells) (Ikonomidou et al., 1999).  On electron microscopy, this neurodegeneration 
was identical to apoptotic cell death, and most evident in the laterodorsal thalamic 
nucleus, one of the areas of the brain implicated in learning and memory (Goen et al., 
2002).  This phenomenon has since been demonstrated in other brain regions with 
other drugs (Monti and Contestabile, 2000). 
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Jevtovic-Todorovic and co-workers showed in their later work showed that neonatal 
rats are vulnerable to harmful side effects of anaesthesia during the synaptogenic 
period.  They demonstrated up to a 68 fold increase in the number of degenerating 
neurones above baseline in areas such as the laterodorsal and anteroventral 
thalamic nuclei (and to some extent layer II of the parietal cortex) after exposure to 
anaesthetic agents (Jevtovic-Todorovic et al., 2003a) – which resulted in a functional 
neurological deficit in behaviour tests later in life.  Specifically, the GABAmimetic gas 
isoflurane (Gyulai et al., 2001), produced dose-dependent neurodegeneration in its 
own right, with synergistic neurodegeneration with the successive addition of 
midazolam (a double GABAmimetic cocktail) and then N2O (a triple cocktail) 
(Jevtovic-Todorovic et al., 2003a).  This process has been shown to occur with 
exposure to GABAmimetics in areas other than anaesthesia, such as anticonvulsant 
therapy and maternal drug abuse in rats (Bittigau et al., 2002; Farber and Olney, 
2003). 
A clinical manifestation of this type of neurodegeneration is detected in 1 to 2 
infants per 1000 livebirths as Fetal Alcohol Syndrome (FAS) (Moore and Persaud, 
1998) - characterised by abnormal facial features, microencephaly and mental 
retardation (Olney et al., 2002c).  It is thought that binge drinking by pregnant 
mothers produces very high levels of ethanol (a dual GABAmimetic and NMDA 
receptor antagonist (Farber and Olney, 2003)) in the fetal brain, which in turn 
triggers the type of neurodegeneration discussed above (Ikonomidou et al., 2000).  It 
is worth noting that this mechanism of action closely resembles that of current 
anaesthetic procedures. 
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Both the NMDA receptor and the GABA receptor have been linked to the mechanism 
of this apoptotic cell death.  Activation of the NMDA receptor can enhance neuronal 
survival both post-translationally (via the PI (3) K-Akt pathway (Brunet et al., 2001)) 
and genomically (via intermediate early genes (Wisden et al., 1990)).  Indeed, the 
NMDA receptor appears to control several key molecules that are either anti-
apoptotic in their own right or produce an anti-apoptotic effect by regulating other 
systems, such as NF-κB (Lipsky et al., 2001; Bhakar et al., 2002) (which is pro-
inflammatory to glial cells (Hardingham and Bading, 2003)) and CREB (Hardingham et 
al., 2002) (which controls a self-supporting pro-survival cascade (Hardingham and 
Bading, 2003)).  Also, the electrical stimulation cells needed to survive is thought to 
be Na
+
 and Ca
2+
 mediated via the NMDA receptor.  On the other hand, high 
concentrations of GABA (e.g. with use of the anticonvulsive valproate) also directly 
suppresses neurotrophins such as BDNF, and attenuates other cell survival cascades 
such as ERK, Akt and c-Raf (Bittigau et al., 2002). It would be reasonable to suppose 
that sustained blockade of the NMDA receptor, combined with facilitation of 
GABAergic transmission, and could shift the cell balance towards pro-apoptosis. 
 
2.6.4 Characterising neurodegeneration 
The Cupric-Silver technique (DeOlmos Silver Staining) has repeatedly been shown to 
be excellent for highlighting the density and distribution of neurodegeneration 
(Beltramino et al., 1993; Jevtovic-Todorovic et al., 2003b).  The process highlights 
argyrophilia (a generalised CNS response to injury (O’Callaghan and Jensen, 1992)) to 
reveal cumulative neurodegeneration, so issues surrounding the small timeframe of 
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marker expression, as in other techniques identifying gene products and enzyme 
activation, do not apply (DeOlmos and Ingram, 1971).  The downfall of silver staining 
is the difficulty in accurately quantifying neuronal injury from fragments. 
 
At the end of the apoptotic signalling cascade, caspase-9 activates caspase-3 (a 
cysteine protease), and thus caspase-3 is a marker of those cells that are 
downstream of the apoptotic commitment point.  While broadly paralleling silver 
staining, caspase-3 immunohistochemistry is superior for both quantification 
purposes and characterisation of physiological cell death (Olney et al., 2002b). 
 
C-fos is one of the immediate early genes that have a role in linking cytoplasmic 
events to nuclear gene transcription (Walton et al., 1998).  As a regulator of gene 
expression, c-Fos indicates a state of neuronal activation, a result of several possible 
different external stimuli, including apoptotic cell death (Dragunow and Preston, 
1995) and pain (reviewed in Duckhyun and Barr, 1995).   C-fos has previously been 
shown to be a sensitive marker of the neurotoxicity of NMDA receptor antagonists in 
adult rats (Ma et al., 2002) and is valid for assessment of NMDA receptor activation 
(Hasegawa et al., 1998).   
 
All intrinsic and extrinsic Apoptotic Pathway involves a cascade of events that 
culminate in apoptotic cell death. Although each pathway is characterised by the 
input of a multitude of proteins, caspase-3, both cytochrome C and caspase-9, and 
caspase-8 are characteristic of the activation of the common, intrinsic and extrinsic 
pathway respectively.  
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2.7 Neurons and brain structures involved in learning 
and memory  
Neurons are the principle cells within the central nervous system (CNS) and based on 
morphology, location, connectivity and chemistry, there are hundreds, if not 
thousands of individual neuronal cell types (Masland, 2004). Synaptic transmission 
between different neurons provides the nervous system with its remarkable 
functional capacity and neurotransmitters are the diverse chemical substances that 
participate in such process. Thus far, more than a hundred neurotransmitters have 
been implicated in synaptic transmission and some of the neurons can be classified 
as glutamatergic, GABAergic, dopaminergic and cholinergic neurons based on the 
neurotransmitters they produce (Steven and Hyman, 2005).  
 
Glutamate is the major excitatory neurotransmitter in the CNS of mammals 
(Shepherd et al., 2007). Although best known for its role at synapses in the mature 
nervous system, glutamate is also of vital importance during development where it 
regulates neurogenesis, neurite outgrowth, synaptogenesis and long-term 
potentiation (LTP) (Suzuki et al., 2006; Mattson, 1996; Kullmann and Lamsa, 2007). 
LTP is the ability to execute cumulative increases in synapse strength that lead to 
long-term memory (Lynch, 2004). However, these glutamate-mediated processes 
could potentially be inhibited by general anaesthetics (Lingamaneni et al., 2001) 
possibly via a process that involves site-specific phosphorylation (Snyder et al., 2007).    
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In contrast to glutamate, Gamma-aminobutyric acid (GABA) is the major inhibitory 
neurotransmitter in the CNS of mammals and GABAergic neurons also play a part in 
learning and memory formation and consolidation (Lüscher and Keller, 2004; Das, 
2003) and activation of gamma-aminobutyric acid type A (GABAA) receptors has been 
shown to downregulate memory consolidation processes (Brioni, 1993). Both 
glutamatergic and GABAergic neurones are widely distributed within the CNS (Foster 
and Kemp, 2005). The hippocampus and neocortex (including cingulate cortex) are 
crucial brain structures for learning and memory (Squire et al., 2004; Wiltgen et al., 
2004; Frankland and Bontempi, 2005; Blum et al., 2006), which contain mainly 
glutamatergic and GABAergic neurons (Sem'yanov, 2005; DeFelipe et al., 2002). So 
far behavioural studies in animals have suggested permanent deficits in 
hippocampus-dependent learning post anaesthetic exposure (Sall et al., 2009; 
Satomoto et al., 2009). Therefore, depletion of glutamatergic and GABAergic 
neurons in the hippocampus and neocortex may well contribute to learning and 
memory deficits observed after anaesthetic exposure.  
 
Acetylcholine (ACh) has been implicated in cognitive processing, arousal, and 
attention in the brain (Picciotto et al., 2002). Studies thus far have also 
demonstrated the importance of cholinergic system in learning and memory 
(Hasselmo, 2006). Blockade of muscarinic cholinergic receptors impairs the encoding 
of new memories in human subjects (Atri et al., 2004; Hasselmo and McGaughy, 
2004). Conversely, drugs that activate nicotinic receptors enhance the encoding of 
new information (Buccafusco 2005). In humans memory deficits associated with 
Alzheimer’s disease and normal aging can be attributed to degeneration of 
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cholinergic basal forebrain neurons, especially in the nucleus basalis of Meynert 
(Muir, 1997; Wu et al., 2005). Moreover, aged rats that demonstrate impairments in 
learning and memory tasks are also characterised as having smaller numbers of 
neurons and greater atrophy of surviving cholinergic neurons in the basal forebrain 
(Koh and Loy 1988; Koh et al. 1989). Within the basal forebrain cholinergic system, 
cholinergic neurons primarily project to the hippocampus and neocortex (Reiner and 
Fibiger 2001) and inhalational anaesthetic agent, isoflurane, has been shown to 
suppress the release of Ach in the rat cerebral cortex (Shichino et al. 1998) and 
dorsal hippocampus (Whittington and Virag 2006) in vivo. However, whether such 
suppression is due to anaesthesia-induced cholinergic neuron death in the basal 
forebrain remains elusive.   
 
In the field of catecholamine transmitters, dopamine pathways have been 
recognised as playing a critical role in cognition and emotion, and recently there has 
been a large increase in the experimental evidence for a role of dopamine in learning 
and memory (Packard and Knowlton 2002; Jay, 2003; González and Feria, 2008; 
Olvera-Cortés et al., 2008; Nieoullon and Coquerel, 2003). Neurochemically the 
hippocampus, neocortex and striatum receive midbrain dopaminergic projections 
from mainly the substantia nigra and ventral tegmental area and release of 
dopamine in these regions can induce an enhancement of long-term potentiation 
(Jay, 2003). Animal studies have shown that intra-hippocampal or intra-striatal 
injections of various dopamine receptor agonists could enhance learning and 
memory consolidation (Packard and White, 1991; Wilkerson and Levin, 1999; 
Packard et al., 1996), whereas the depletion of dopamine leads to the opposite 
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(Wilkerson and Levin, 1999; Roeltgen and Schneider, 1994; Adriani et al., 1998). In 
Parkinson’s disease, cell death in the substantia nigra leads to a loss of dopaminergic 
output (Schapira, 2009) and behavioural studies in patients with Parkinson’s disease 
have demonstrated that the circuitry required for learning the stimulus-response 
associations is disrupted (Knowlton et al., 1996). Several in vivo studies thus far have 
indicated that anaesthetics could potentially have an impact on dopaminergic 
neurons as the level of dopamine in the striatum could be increased by anaesthetic 
exposure (Adachi et al., 2000; Adachi et al., 2005). Also, general anaesthetics with 
the neurotoxin, 6-hydroxydopamine could significantly increase the extent of 
nigrostriatal dopaminergic neuronal loss (Datla et al., 2006). Therefore, anaesthetic 
exposure during the period of rapid synaptogenisis may lead to increased 
dopaminergic neuronal cell death in the substantia nigra and ventral tegmental area, 
which could contribute to the learning and memory deficits observed later in life.  
 
2.8 Preconditioning 
The phenomenon of preconditioning was first described by Murry and has since 
evoked great interest because of its potential as a pre-emptive treatment against 
cell, tissue and organ damage (Murry et al, 1986; Grimm et al, 2005). There is no 
established definition for preconditioning but it can be thought of as the brief 
presentation of a sub-lethal stressor providing protection, presumably by rendering 
vulnerable tissue more “tolerant” to a greater injury (Yellon et al, 1998). This occurs 
due to transient augmentation of endogenous adaptive responses that induce 
protection (Gidday, 2006). 
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Adaptation to a preconditioned state is biphasic, namely acute and delayed. Acute 
preconditioning occurs within minutes but is relatively short lived, providing 
protection as a result of adaptation of membrane receptors, ion channel 
permeabilities, protein phosphorylation and other post-translational modifications 
(Gidday, 2006). Delayed or “classical” preconditioning requires many hours or days 
to fully manifest. These late effects are the result of gene up-or down-regulation 
(Steiger and Hanggi, 2007) and are dependent on denovo proteion sythesis 
(Meldrum, 1997). Therefore delayed preconditioning can be though to genetically 
“reprogramme” the cell’s response to a particular insult (Gidday, 2006). Commonly 
know preconditioning agents include hypoxia, ischaemia and pharmacological 
agents.   
 
2.8.1. Cross tolerance 
While the original studies involved hypoxia or ischaemia, the early elucidation of the 
molecular mechanisms involved in the process of HI preconditioning raised the 
possibility of manipulating those targets pharmacologically. Therefore, a plethora of 
agents have been investigated; the most clinically promising of these are anaesthetic 
agents because of their possible application in elective, high-risk surgical patients. 
The putative therapeutic utility of anaesthetic preconditioning, especially for injury 
to the CNS, exceeds that induced by a strategy involving hypoxia and/or ischaemia 
because the latter strategy has a narrower safety margin. These studies introduced 
the notion of “cross tolerance”, where preconditioning against HI injury may be 
induced not only by hypoxia or ischaemia but also by a diverse variety of metabolic 
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or physical stressors, or pharmacological agents.  However, the cross-induction of 
pharmacological-induced tolerance may differ in efficacy compared with hypoxic or 
ischaemic preconditioning and the protection is often governed by multiple 
mechanisms. 
 
2.8.2 Anaesthetic preconditioning  
A notable form of pharmacological preconditioning is anaesthetic preconditioning 
where certain inhalational anaesthetics, such as halothane, isoflurane and 
sevoflurane, have been demonstrated as effective inducers of acute and delayed 
preconditioning (Piriou et al., 2002). Anaesthetic preconditioning has also been 
successfully trialled in humans and is a promising therapy for surgical patients at 
high risk of developing ischaemic complications. Particularly relevant to this study, 
neuroprotection by preconditioning with xenon has recently been demonstrated in 
our laboratory (Ma et al., 2006), although the underlying molecular mechanisms 
remain to be elucidated. 
 
Pre-exposure to xenon for 2 hours resulted in a decrease in the release of lactate 
dehydrogenase (a marker for neuronal injury) following oxygen-glucose deprivation 
of cultured neuronal-glial cells (Ma et al., 2003a). This delayed preconditioning effect 
of xenon indicates a role for the anaesthetic in protecting against neonatal asphyxia. 
What remains to be elucidated is whether these neuroprotective properties are 
observed when neuronal death is induced by other insults, such as anaesthetics, 
during the period of synaptogenesis. 
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2.8.3 Hypoxic/Ischaemia preconditioning 
Hypoxic preconditioning refers to a period of hypoxia followed by a period of time, 
often between 1 to 2 days, during which there is protection from an otherwise lethal 
insult (Sharp et al., 2004). Like ischemic preconditioning, it requires the synthesis of 
new RNA and protein, similar to the mechanism of xenon preconditioning (a 
reference needed). Hypoxia – induced tolerance in the brain has been reported to 
be blocked by the presence of inhibitor of RNA and protein synthesis (Gage and 
Station, 1996). This suggests that an increase in transcription and translation are 
necessary for protection. Recent studies have demonstrated that hypoxia can 
damage mitochondrial DNA in brain cells (Wang et al., 2000) which stimulate 
protective mechanisms. These could play an important role in the cellular protection 
afforded by hypoxic preconditioning. Indeed, a study by (Gidday et al , 2005) first 
showed that exposure of  neonatal rat pups to hypoxia alone (8% oxygen for 3 hours) 
provided a protection against injury induced by combined hypoxic/ischemia, as well 
as several other type of injury such as oedema and seizures (Gage and Station, 1996; 
Miller, 2001). 
 
2.9 Neuroprotection by xenon 
Xenon, deriving its name from the Greek for “stranger”, is an inert and extremely 
rare noble gas, constituting no more than 0.0875 parts per million of the 
atmosphere. Xenon was fist demonstrated to possess anaesthetic properties in 
humans in 1951 by Colleen and Gross. It is a small apolar atom with a low blood/gas 
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partition coefficient; it is able to easily pass through the blood brain barrier and 
produce a rapid onset and offset of action (Goto et al., 1998), an advantageous 
property for an inhalational anaesthetic drug. Xenon does not affect heart rate, 
mean arterial blood pressure (Dingley et al., 2001) or cardiac contractility (Luttropp 
et al., 1993) nor does it impair the neurohormonal stress response to surgery (Burov 
et al., 1995). Animal studies conducted by (Lane et al., 1980) demonstrated xenon to 
be devoid of any fetotoxicity. Thus, its safety and efficacy profile in clinical 
anaesthesia appears unrivalled; its scarcity in the atmosphere, and hence the 
substantial expense involved in its purification, is the only factor limiting its 
widespread use (Sanders et al., 2003).  
 
Franks and co-workers, working in this laboratory, were the first to describe in a 
seminal paper that xenon is a potent antagonist of the NMDA receptor (Franks et al., 
1998). In a series of in vitro  studies xenon reduced injury in a mouse neuronal –glial 
cell co-culture induced by either NMDA, glutamate, oxygen deprivation or oxygen-
glucose deprivation(OGD) (Wilhelm et al., 2002); this finding has been corroborated 
with the results of others studies in a different neural crest cell line (Petzalt et 
al.,2004). 
 
The neuroprotective effects of xenon have also been demonstrated in vivo models 
of acute neuronal injury involving administration of excitotoxins to rats (Ma et al., 
2002), anaesthetics-induced apoptotic neurodegeneration in neonate, 
cardiopulmonary bypass in rats (Ma et al., 2003b), middle cerebral artery occlusion 
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in mice (Homi et al., 2003), cardiac arrest in pigs (Schmidt et al., 2005), and hypoxia-
ischaemia in neonatal rats (Ma et al., 2006). 
 
Xenon is a more efficacious neuroprotective agent than gavestinel or dizocilpine (MK 
801) (Ma et al., 2005b), two other NMDA antagonists that have been clinically tested. 
Importantly, xenon lacks the toxicity that afflicts other NMDA receptor antagonists 
(Ma et al, 2002). These studies establish that xenon has a potent neuroprotective 
effect once injury has occurred. Furthermore, xenon is able to prevent neurotoxic 
damage caused by other NMDA antagonists (Nagata et al, 2001). 
 
2.10 Target protein in the pathway of protect apoptosis  
2.10.1 Bcl-2 family         
Bcl-2 closely related anti-apoptotic homologues such as Bcl-x exert control of 
mitochondrial permeability by stimulating ADP/ATP exchange, stabilizing the 
mitochondrial inner transmembrane potential, and preventing the opening of a 
permeability transition pore that enables the release of cytochrome c. There are 
similarly structured proapoptotic Bcl-2 family members such as Bax or Bak that can 
promote mitochondrial permeability via their direct effects on the mitochondria or 
indirectly through inhibition of Bcl-2 (Dejean et al, 2006). All of these Bcl-2 family 
members are present in outer mitochondrial membranes as dimmers with a 
structure analogous to that of diptheria toxin where they directly control membrane 
permeability in ion channel fashion (Martinez-Caballero et al., 2005).  Likewise, in 
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mammals similar cytoplasmic proapoptotic Bcl-2 family members such as Bad or Bik 
have been identified with only limited homology to Bcl-2. Following apoptotic 
stimulation they translocate to the mitochondria and block the protective regulatory 
activity of Bcl-2 by binding to the conserved Bcl-2 surface. A third type of Bcl-2 
family protein is exemplified by the cytoplasmic protein BID which has limited 
sequence homology to Bcl-2. When BID is cleaved by activated caspase-8, it assumes 
a structure like Bcl-2, translocates to the mitochondria, and independently inserts 
and induces channel formation in the membrane (Desagher et al., 2000; Cory  et al., 
2003; Green et al., 2004). 
 
2.10.2 Cytochrome c 
There is considerable evidence that disruption of mitochondrial functions (e.g. loss 
of transmembrane potential, permeability transition (PT) and release of cytochrome 
c leading to impaired electron transport) are important events in many apoptotic 
cell deaths . The release of cytochrome c induced by a variety of death stimuli results 
in the activation of a complex of apoptosis-activating factor 1 (Apaf-1) and caspase-9, 
leading to the cytochrome c dependent processing of pro-caspase-3 and apoptosis in 
a number of scenarios. There is evidence that caspase-3 activation can also occur 
independently of mitochondrial cytochrome c release. For example, two cell type-
dependent death pathways emanating from the Fas receptor have been discovered. 
In type II cells, apoptotic cell death was inhibited by Bcl-2 and depended on the loss 
of mitochondrial functions; whereas in type I cells, apoptosis (involving caspase-3 
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activation) was not blocked by Bcl-2 even though Bcl-2 prevented disruption of 
mitochondrial functions including cytochrome c release.  
 
In multiple myeloma cells, there exist cytochrome c-dependent and -independent 
mechanisms of apoptosis, both of which involve caspase-3 activation. Once caspase-
3 is activated, downstream death substrates are cleaved irrespective of the 
involvement of cytochrome c. But caspase-3 might also amplify the upstream death 
cascade, including cytochrome c release from mitochondria, by cleaving Bcl-2, 
converting it from an anti-apoptotic to a pro-apoptotic protein. Together these 
results indicate that mitochondria certainly play a role in apoptosis, but also mean 
that in some situations caspase-3 is activated when the mitochondrial step is 
completely bypassed. Furthermore, the release of cytochrome c can theoretically 
occur downstream of caspase-3 in some instances, and apoptotic cell death does not 
always involve the cytochrome c-dependent activation of caspase-3. Curiously, the 
introduction of some pro-apoptotic proteins into cells causes death independently 
of caspases. Enforced expression of pro-apoptotic members of the Bcl-2 family (e.g. 
Bax) kills mammalian cells, accompanied by membrane alterations and DNA 
condensation, but without DNA fragmentation and caspase activation. These studies 
on the expression of Bax like proteins are consistent with the conclusion that DNA 
fragmentation requires functional caspase-3 and, importantly, imply that not all 
morphological changes in dying cells require caspases. The fact that Bax can cause 
cytochrome c release and promote mitochondrial PT or puncture the mitochondrion 
in a caspase-independent fashion further emphasizes the importance of the 
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disruption of mitochondrial functions in apoptosis ( Jiang et al., 2004; Liu et al., 1996; 
Zou  et al., 1997; Li  et al., 1997; Yang  et al., 1997). 
 
2.10.3 P53  
P53 is a transcription factor that regulates the cell cycle and hence functions as a 
tumor suppressor. It is important in multicellular organisms as it helps to suppress 
cancer. P53 has been described as "the guardian of the genome", "the guardian 
angel gene", or the "master watchman", referring to its role in conserving stability 
by preventing genome mutation. P53 has many anti-cancer mechanisms: It can 
activate DNA repair proteins when DNA has sustained damage. It can also hold the 
cell cycle at the G1/S regulation point on DNA damage recognition (if it holds the cell 
here for long enough, the DNA repair proteins will have time to fix the damage and 
the cell will be allowed to continue the cell cycle). It can initiate apoptosis, the 
programmed cell death, if the DNA damage proves to be irreparable.  
 
P53 is also a pivotal molecule regulating the death of neurons both after acute injury 
and during the development. The p53 tumour suppressor gene is involved in the 
regulation of apoptosis in a number of different paradigms. As a tumour suppressor, 
the best understood function for p53 is to mediate cell cycle arrest or apoptosis 
after DNA damage, thereby preventing the propagation of damaged cells (Ko et al., 
1996). Aberrant cell cycle regulation during development, such as the widespread 
CNS defect in Rib null transgenic mice, evokes a p53-mediated apoptosis (Clarke et 
a.l, 1993; Jacks et al., 1994; Lee et al., 1993). 
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2.10.4 MAP Kinase and phosphate MAP Kinase 
Mitogen-activated protein (MAP) kinases are serine/threonine-specific protein 
kinases that respond to extracellular stimuli (mitogens) and regulate various cellular 
activities, such as gene expression, mitosis, differentiation, and cell 
survival/apoptosis. The MAPK/ERK pathway is a signal transduction pathway that 
couples intracellular responses to the binding of growth factors to cell surface 
receptors. This pathway is very complex and includes many protein components 
(Orton  et al., 2005). Protein phosphorylation presents a mechanism by which the 
activity of numerous proteins in the form of enzymes, receptors, transporters, 
docking and scaffolding proteins is switched on or off across a wide array of 
biological processes from cell growth and differentiation through apoptosis to 
disease.  Human genome may encode as many as 2000 protein kinase to 
phosphorylate amino acid residues serine, threonine and tyronine and tyrosine 
within these proteins in various tissues, cell lines and organelles. 
 
 
 
2.11 Central pain pathway 
The pathways that carry information about noxious stimuli to the brain, as might be 
expected for such an important and multifaceted system, are also complex. It helps 
in understanding this complexity to distinguish two components of pain: the sensory 
discriminative component, which signals the location, intensity, and quality of the 
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noxious stimulation and the affective motivational component of pain—which 
signals the unpleasant quality of the experience, and enables the autonomic 
activation that follows a noxious stimulus (the classic fight-or-flight reaction). 
 
The discriminative component is thought to depend on pathways that target the 
traditional somato sensory areas of cortex, while the affective motivational 
component is thought to depend on additional cortical and brainstem pathways.  
 
Pathways responsible for the discriminative component of pain originate with other 
sensory neurons, in dorsal root ganglia and, like other sensory nerve cells the central 
axons of nociceptive nerve cells enter the spinal cord via the dorsal roots. When 
these centrally projecting axons reach the dorsal horn of the spinal cord, they 
branch into ascending and descending collaterals, forming the dorsolateral tract of 
Lissauer. Axons in Lissauer’s tract typically run up and down for one or two spinal 
cord segments before they penetrate the gray matter of the dorsal horn. Once 
within the dorsal horn, the axons give off branches that contact neurons located in 
several of Rexed’s laminae (these laminae are the descriptive divisions of the spinal 
gray matter in cross section, again named after the neuroanatomist who described 
these details in the 1950s). 
 
The axons of these second-order neurons in the dorsal horn of the spinal cord cross 
the midline and ascend all the way to the brainstem and thalamus in the 
anterolateral (also called ventrolateral) quadrant of the contralateral half of the 
spinal cord. These fibers form the spinothalamic tract, the major ascending pathway 
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for information about pain and temperature. This overall pathway is also referred to 
as the anterolateral system, much as the mechanosensory pathway is referred to as 
the dorsal column–medial lemniscus system. 
 
The location of the spinothalamic tract is particularly important clinically because of 
the characteristic sensory deficits that follow certain spinal cord injuries. Since the 
mechanosensory pathway ascends ipsilaterally in the cord, a unilateral spinal lesion 
will produce sensory loss of touch, pressure, vibration, and proprioception below 
the lesion on the same side. The path-ways for pain and temperature, however, 
cross the midline to ascend on the opposite side of the cord. Therefore, diminished 
sensation of pain below the lesion will be observed on the side opposite the 
mechanosensory loss (and the lesion). This pattern is referred to as a dissociated 
sensory loss and together with local dermatomal signs. 
 
2.11.1 c-Fos  
2.11.1.1 c-Fos expression in nociceptive pathways in the brain 
While the majority of studies on c-Fos and nociception have focused on expression 
in the spinal cord, several studies have used c-Fos expression to investigate 
nociceptive processing in the brain. Elizabeth Bullitt (Bullitt, 1989; Bullitt, 1990) 
examined c-Fos expression in the brainstem, hypothalamus, and thalamus in rats 
subjected to noxious mechanical stimulation (paw pinch) or noxious thermal 
stimulation (immersing a paw in hot water). She reported that these forms of 
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noxious stimulation induced c-Fos expression in the dorsal reticular nucleus, central 
gray, dorsal raphe, parabrachial nucleus, inferior colliculus, the lateral hypothalamus, 
and the midline and intralaminar thalamic nuclei. Other studies have confirmed that 
c-Fos is expressed in neurons in the dorsal and lateral reticular nuclei (Carstens et al., 
1995; Lanteri–Minet et al., 1994), the cuneiform nucleus (Lanteri–Minet et al., 1994), 
the parabrachial nucleus (Bellavance et al., 1996; Hermanson et al., 1996; Lanteri–
Minet et al., 1994; Pertovaara et al., 1993), the PAG (Keay et al., 1993; Lanteri–Minet 
et al., 1994), the hypothalamus (Pan et al., 1994), and the medial thalamus 
(Pertovaara et al., 1993). This distribution of c-Fos expression is much as one would 
expect based on tracing and electrophysiological recording studies. However, rather 
than simply confirming what had already been established by electrophysiological 
recording techniques, these studies have shown that c-Fos expression can be used 
to identify nociceptive processing in cell groups of restricted extent (e.g., in the 
various nuclei in the intralaminar and midline thalamus), which would be almost 
impossible using electrophysiological recording. Thus, c-Fos can be used to make 
fine-grained delineations about the precise areas that are activated by noxious 
stimulation, as well as revealing the overall distribution of neuronal populations that 
respond to that stimulation. An excellent illustration of this can be seen in the work 
of Keay and Bandler (Keay et al., 1993), who used c-Fos expression to investigate 
which regions of the PAG are activated by different types of noxious stimuli. They 
found that cutaneous noxious stimulation (produced by radiant heat) induced c-fos 
expression predominantly in the lateral and dorsolateral segments of the PAG, 
whereas the c-Fos induced by deep noxious stimulation (injection of dilute formalin 
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into the muscles of the neck) showed a strong predilection for the ventrolateral 
quadrant of the PAG. 
Several other brain regions, not traditionally viewed as contributing to nociception, 
have been shown to contain neurons which express c-Fos in response to noxious 
stimulation. For example, numerous studies have reported that noxious stimuli elicit 
c-Fos expression in the locus coeruleus (Jones et al., 1995; Smith et al., 1994). While 
this structure was once believed to receive direct nociceptive input from the spinal 
cord, a recent investigation has established that neurons in the spinal cord do not 
project to this structure (Aston-Jones et al, 1994). Noxious stimulation has also been 
shown to elicit c-Fos expression in neurons in the superior colliculus, but this 
expression was seen bilaterally even though the noxious stimulus was applied 
unilaterally (Telford et al., 1996). Moreover, the distribution of Fos-labeled neurons 
in the superior colliculus did not differ when the noxious stimulus was applied to the 
hind paw or to the face, indicating that this structure does not encode information 
about the location of noxious stimulation. 
 
Finally, peripheral noxious stimulation has been shown to induce c-Fos expression in 
cells of the anterior pituitary that was also immunoreactive for adrenocorticotropic 
hormone and beta-endorphin (Pan et al., 1994; Pan et al., 1996). While c-Fos 
expression was induced by noxious stimulation in each of these structures, it is 
unlikely that they play a role in nociception. Rather, the observed c-Fos expression 
most likely reflects the role these structures play in the stress response elicited by 
pain. 
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2.11.1.2 Activation of c-Fos during development.  
Gubits et al. (1988) studied the levels of c-Fos expression in the brain at different 
stages of development. They showed that higher levels of c-Fos mRNA occurred in 
the rat brain between birth and postnatal day 16 (P16). The highest levels of c-Fos 
mRNA were seen in meninges at embryonic day 18 (E18) and cerebral cortex and 
cerebellum at P30. At this stage (P30), only low levels of c-Fos mRNA were detected 
in the hippocampus and in striatum. The levels of c-Fos mRNA in the whole brain 
attained at P30 were maintained up to 1.5 years of age in male activation of c-Fos in 
the rat brain. A transient decrease in these levels was seen at P50, raising the 
question of whether this decrease is related to the onset of puberty in males. It was 
suggested that the expression of c-Fos could be related to synaptogenesis and 
differentiation rather than to mitosis. An in situ hybridization study by Caubert (1989) 
investigated the expression of c-jios mRNA in the developing brain. Around 
embryonic day 12 (E12), high levels of c-Fos were seen throughout the CNS. At later 
stages, the expression of c-Fos was confined to limited areas of the cerebellum, 
spinal cord, forebrain and retina (Pan et al., 1996). A fos-LacZ transgenic mouse had 
been recently used to study the developmental expression of the transgene 
(Smeyne et al., 1993). Expression of the transgene that was observed at PO in 
olfactory bulb, hippocampus retrosplenial cortex and thalamic nuclei, decreased to 
adult levels by 3 weeks. This again suggests that c-Fos may play a role in the CNS 
during development (Smeyne et al., 1992). Northern blot analysis has shown low 
levels of c-fos mRNA which increases within Pl3-P30 (Gubits et al., 1988; McCormack 
et al., 1992).  Developmental differences in expression of c-Fos in the brain have also 
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been observed after seizure induction (Schreiber et al., 1992; Jensen et al., 1993). 
The PTZ administration in rats resulted in increase in c-Fos immunoreactivity in 
superficial layers of retrosplenial, cingulate and neocortex in adults but only deep 
layers in P10 rats were affected (Jensen et al., 1993). Similarly, KA administration 
resulted in increase in c-Fos expression in limbic structures in adult animals but not 
in pups prior to P13 (Schreiber et al., 1992). The effects of PTZ, fluorothyl and 
hypoxia were studied in immature rats (postnatal day 10) and compared with that in 
adult rats. The CFLIR after PTZ or fluorothyl-induced seizure was elevated in 
amygdala, piriform cortex and hypothalamus at both ages; superficial layers of 
retrospenial, cingulate and neocortex were stained in adults but staining was 
confined to deep layers of neocortex in Pl0 rats. Intense staining at 2 hr after seizure 
onset was reduced at 4 hr in adults but IR was not seen until 4-6 hr after seizure in 
Pl0 rats. The CFLIR within the dentate gyrus and hippocampus occurred only after 
prolonged seizures. Hypoxia, which produced seizures in Pl0 rats, induced CFLIR in 
the layer VI of neocortex but rarely involved limbic structures (Jensen et al., 1993). 
 
Differential regulation of c-Fos expression during development after brain injury has 
been reported (Herrera et al., 1993). Rats that were inflicted with a mechanical 
cortical injury at post-natal day (PD) 10 or 15, and sacrificed 1.5 hr after, did not 
show an increase in c-fos immunoreactivity far from the wound, but some of these 
animals did show c-Fos immunoreactive (IR) nuclei close to the lesion (PD 15). At PD 
22, cortical injury produced an increase in c-Fos IR nuclei in the piriform cortex 
ipsilateral but not contralateral to the lesion. This pattern was maintained up to PD 
360 (Herrera et al., 1993). Similarly, the presence of c-Fos IR cells was observed in 
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the ipsilateral cingulate cortex from PD 22 onward. Ruppert and Wille (1987) 
showed that disruption of the cerebellum at P3 and up to P7 was followed by a 
massive increase in c-Fos mRNA (Ruppert and Wille, 1987). This effect was not seen 
in the adult animal with similar injury. This finding shows a clear differential 
regulation of c-Fos during development and may help to explain, at least partially, 
the different clinical outcomes seen in children and in adults after head trauma. 
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CHAPTER 3                                                       
GENERAL METHODS AND EXPERIMENT MODELS 
 
 
 
 
 
 
 
 
                                                                                                                                                                             Yi Shu 
Imperial College London                                                     63                                                                                    Dec 2010   
This study was approved by the Home office (UK) and conforms to the United 
Kingdom Animals (Scientific Procedures) Act of 1986. All efforts were made to 
minimise any animal suffering and the minimum number of animals necessary to 
achieve statistical significance were used. 
 
3.1. Animals 
3.1.1. Neonatal rats 
Postnatal day 7 (PND7) Sprague-Dawley (SD) rat pups (Harlan UK) were used for in 
vivo, in vitro and behavioural experiments. They were housed in a 12-hour-light/12-
hour-dark schedule, with temperature (24°C) and humidity (23%) controlled 
conditions and had access to food and water ad libitum. The data of the birth was 
defined as day 0. On PND 7 which is the period of synatogenesis (Clancy et al, 2001), 
pups were used for experiments. 
 
3.2 Monitoring 
All rats were kept normothermic throughout gas exposure using a water bath. After 
initial equilibration, the composition of the chamber gas was analysed by a gas 
monitor (Datex, Capnomac Ultima). Given the inert chemical characteristics of xenon, 
a specific 439 XE analyser (Air Products, Surrey UK) was used to monitor and verify 
the delivery of the anaesthetic concentration of xenon based on radiofrequency. 
 
                                                                                                                                                                             Yi Shu 
Imperial College London                                                     64                                                                                    Dec 2010   
3.3 Gas Exposure 
3.3.1. Neonatal gas exposure in vivo 
3.3.1.1 Anaesthetics exposure for neuroapoptois in the high centre 
brain study 
Seven day old Sprague-Dawley rats were exposed to oxygen along with one of 
several gas combinations (nitrogen, 70% nitrous oxide, 0.75% isoflurane, 70% N2O + 
0.75% isoflurane,) for 6 hours (n = 3-5/group). The rats were sacrificed after 
anaesthesia, and their brains processed to assess the severity of apoptosis (using 
caspase-3 immunohistochemistry, western blotting). 
 
3.3.1.2 Anaesthetics exposure for neuroapoptois in the spinal cord 
study 
Seven day old Sprague-Dawley rats were exposed to oxygen along with 70% N2O + 
0.75% isoflurane for 6 hours (n = 3-5/group).  The rats were sacrificed after 
anaesthesia, and their spinal cord processed to assess the severity of apoptosis 
(using caspase-3 immunohistochemistry). 
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3.3.1.3 Preconditioning  
3.3.1.3.1. Preconditioning with hypoxic ischemia 
Seven day old Sprague Dawley rat pups were pre-treated with, 8% oxygen (hypoxia) 
or ischemia by ligating the right carotid artery. They were then exposed to the 
anaesthetic combination of 70% N2O +0.75% isoflurane for 6h. The brains were 
removed immediately after anaesthetic exposure and sectioned for Cresyl Violet 
(fissl) Staining. 
 
3.3.1.3.2. Preconditioning with anaesthetics  
Seven day old Sprague Dawley rat pups were pre-treated with one of the following: 
70% xenon, 70% N2O, 8% oxygen (hypoxia). They were then exposed to the 
anaesthetic combination of 70% N2O + 0.75 % isoflurane for 6h. The brains were 
removed immediately after anaesthetic exposure and sectioned for 
immunohistochemistry of caspase 3, a marker of cell apoptosis. In other cohorts 
solely pre-treated, the brains were harvested for western blotting.  70% xenon 
balanced with O2 was delivered through a customised-built anaesthetic machine 
modified for xenon delivery (Ohmeda, Surry, UK). In order to save xenon a closed-
circult was used (Figure 3.1).  
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Figure3.1 Experiment set up.  
A. Gas delivery: (a) xenon monitor; (b) gas delivery equipment; (c) xenon closed circuit; (d) 
custom built anaesthetic chamber. B. Custom built anaesthetic chamber with 6 individual well, (a) 
main inflow of gas branching into 6 smaller tubes leading to wells; (b) sillica gel and soda lime; (c) 
individual well with tube connected to lid to allow outflow of gas; (d) water bath kept 
normothermic (37°C). 
 
 
Slilica gel was added to the chamber to eliminate moisture and soda lime to absorb 
carbon dioxide. 70% N2O balanced with O2, and 8% O2 balanced with nitrogen was 
delivered by a calibrated anaesthetic machine. Exposure times were chosen based 
on previous studied (Sharp et al, 2004; Ma et al, 2007). Gases for all other groups 
were delivered in a high-flow open-circuit, using a calibrated flow meter. 
 
 
3.3.1.4. Nociceptive Stimulation during anaesthetics gas exposure 
Separate cohorts (n= 4 per group) of 7-day- old, littermate Sprague-Dawley rat pups 
were randomly assigned to six groups: 1. Naïve (room air); 2. Anaesthetics alone 
(70% nitrous oxide and 0.75% isoflurane for 6 hrs); 3. Formalin injection alone 
(subcutaneous injection of 10 µl 5% formalin into the left hind paw); 4. Anaesthetics 
+ formalin injection; 5. Surgical incision alone (1 cm midline cut to the left hind paw); 
6. Anaesthetics + surgical incision. The remaining gas constituents were 25% oxygen 
in groups 2-6 and balanced with nitrogen where necessary. To comply with the 
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Animals Act which prevents animals from being subjected to pain without 
administration of a general anaesthetic drug, the surgical incision and formalin 
injection were conducted 10 minutes after the rats were anaesthetised with 70% 
nitrous oxide and 0.75% isoflurane in groups 3 and 5; they were then exposed to 
room air rather than anaesthetic reagents for 6 hours. 
 
3.4 Tissue Fixation 
3.4.1 Brain perfusion 
Rats destined for immunohistochemistry study were terminated by administering an 
overdose of pentobarbitone (100mg/kg) intraperitoneally. One vial of Heparin 
(Elkins-Sinn, 10,000 units /ml) was mixed with 1-liter saline.  Fill 60 cc syringes with 
saline and 4% paraformaldehyde saline can be Hank’s Balanced Salt Solution, sterile 
saline, or PBS. The rats were mounted onto the rack in the sink using butterfly 
clamps.  A cross-sectional incision was made beginning just below the sternum and 
cutting through the abdominal muscles to the beginning of the rib cage.  The 
sternum was held with a large haemostat and the thoracic cage was pulled over the 
head while cutting along each side of the thoracic cage with scissors. The diaphragm 
was cut with scissors. A small haemostat clip was applied to the tip of the heart and 
laid across the abdominal region to hold the heart in a firm position. The perfusion 
cannula was inserted into the left ventricle. A small incision was made in the right 
ventricle with scissors.  60ml of saline with Heparine was infused followed by 60ml of 
4% paraformaldehyde. The hemostats and the perfusion cannula were removed 
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after infusion of the solutions. Thereafter, in the sink, the rats were decapitated 
using the guillotine.  An incision was made with a scalpel from anterior to the eyes to 
just posterior of the ears in order to completely expose the cranium.  The patriotism 
was scraped to the side and the muscles and tendons detached around the cranium. 
The skull was removed with rongeurs by working from posterior cerebellum to 
anterior olfactory bulb. After the entire cortex was exposed, the dura was carefully 
cut with scissors and forceps. Using a flat-ended spatula, the olfactory bulbs were 
severed and afterwards the spatula was placed under the anterior cortex and the 
brain was gently lifted. The optic nerves were severed and the brain was removed 
and placed in 4% Para formaldehyde for 24 hours. It was then immersed in 30% 
sucrose with PB and 1% sodium azide, and refrigerated until the brain sank. It was 
then embedded and frozen into O.C.T solution and sliced corneally into section 
30um thick using a cryostat (Bright Instrument Company Ltd., Huntingdon, UK). 
 
3.4.2 Paraffin embedding and sectioning 
On the day of embedding, the paraffin was melted in the vacuum oven for later use. 
The 70% E/S was decanted from the storage vial, care was taken to avoid disturbing 
the brain. 95% ethanol was added to dehydrate the embryos and rock on a nutator. 
The 95% ethanol was decanted and 100% ethanol was added – rock on nutator. 
Immerse the brains in infiltrating paraffin for one hour. The brains were immersed in 
the embedding paraffin for another hour. To begin with, the tissue-embedding hot 
plate was turned on for pre-warming. Metal mood(s) with paraffin were carefully 
cleaned with ethanol using Kim wipes. After drying, the mood were filled with 
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embedding paraffin liquid and placed into the vacuum oven for pre-warming and for 
dissipating air bubbles. This usually took about 10 min.  The brains were transferred 
(from the embedding paraffin) to the pre-warmed wax mood. Brains were oriented 
to stand on their head in the mood with their longitudinal axis in an upright position 
and their body axis perpendicular to the bottom surface. The mood was placed on 
the hot plate and gradually moved to cooler regions of the plate. After a few minutes 
the mood was removed from the hot plate and placed on the cold plate. Once all of 
the brains in the mood were standing on their heads in similar orientation and at 
some distance from each other, a bit more paraffin was gently added. More paraffin 
was added to fill the chuck. Once solidified, the wax mold was placed at -20°C to 
harden overnight. 100% EtOH was used to clean a container of the water bath which 
was used for spreading the sections. The container was filled, to 80% of the 
container height, with sterile ddH2O and the water warmed to 39 - 42°C. The suitable 
temperature differs among tissue blocks, but 40 - 42°C is a common starting point. 
 
The lock handle was released on the right side. We set the section thickness to 5mm 
on the control panel. The wax block was mounted onto the chuck holder and the 
angle control knobs was losened to allow the relative position of the chuck holder to 
be adjusted with respect to the cutting blade. 
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3.4.3 Brain harvesting 
Rat pups were sacrificed after finishing gas exposure and treatment, the brains were 
immediately removed. They were separated into cortex, hippocampus and 
hypothalamus. The tissues were frozen using liquid nitrogen at -80°C. 
 
3.4.4 Hippocampal slice fixation 
The study protocol was approved by Home office (UK) and conforms to the United 
Kingdom Animals (Scientific Procedures) Act, 1986. 
 
Organotypic hippocampal slices were prepared according to the interface culture 
method as modified by (Sullivan et al, 2001). In brief, neonatal rat pups (PND9/10) 
were anaesthetised using 0.5% isoflurane until quiescent and sacrificed by 
decapitation. The brain was quickly dissected and placed in ice cooled (4°C) 
dissection solution to reduce extraction-induced ischemia (200ml high sucrose-
glucose (HSG) solution,64ml Hanks-balanced salt solution (HBSS) (Gibco) and 0.6ml 
Antibiotic-Antimycotic solution (AAS) (Sigma)). All stages of slice preparation were 
carried out under sterile and ice-cooled conditions. 
          
Excess tissues (cerebellum, olfactory bulbs and meninges) were removed and the 
brain cut into 400 µm saggital slices using a Mclllwain Tissue Chopper (Mickle 
Laboratory, Cambridge, UK). Under a microscope (Zeiss W-Pl 10*) and cooling light 
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(KL 1500, Schott), the slices were separated using fine forceps, avoiding contact with 
the hippocampus. 
 
Slices with hippocampus were selected and placed onto 30mm diameter semiporous 
cell culture inserts (Falcon, Becton Dickinson Labware, Millipore, and Bedford, MA, 
USA). Five slices were positioned on each insert and placed in a 6-well Tissue Culture 
Tray (Multiwell TM Falcon, Becton Dickinson labware, Bedford, MA, USA) Growth 
media (1.5ml) (made up with: 282ml Medium Stock (Gibco/Life technologies), 32 ml 
Horse Serum, 32ml Foetal Bovine Serum and supplemented with 3.2ml Glutamine 
and 3.2 AAS (Gibco/Sigma)) was then transferred to each well. 
      
The slices were incubated for 24 hours in humidified air at 37°C, enriched with 5% 
Carbon Dioxide to allow for recovery from the trauma induced by the extraction. The 
culture medium was replaced the following day with fresh, equilibrated medium.   
 
The gases were delivered by a standard anaesthetic machine through the chambers 
at 2-3L/min. The gases were analysed using an S/5 spirometry module (Datex-
Ohmeda, Bradford, UK) and xenon was monitored using a 439XE monitor (Air 
Products, UK) due to xenon’s inert chemical characteristics. After 3 minutes of gas 
flow the chambers were sealed and placed in a 37°C (Galaxy R Carbon Dioxide 
Chamber, Wolf Laboratories). 
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3.5 Immunohistochemistry 
3.5.1 Solutions 
0.2 M Phosphate buffer (PB) (2 L) 
46 g Na2HPO4 
9.1 g Na2H2PO4 
2 L dH2O 
0.1 M Phosphate-buffered saline (PBS) (2 L) 
1 L 0.2 M PB 
1 L dH2O 
18 g NaCl 
0.1 M Phosphate-buffered saline with 0.3 % triton (PBS-T) (2 L) 
2 L PBS 
6 mL Triton X-100 (Promega) 
0.1M Phosphate-buffered saline with 0.3 % H2O2 / 70 % methanol (30 mL) 
9 mL 0.1 M PBS 
21 mL Methanol 
300 μL 30% H2O2 
Heparinised phosphate-buffered saline (PBS-Hep) (2 L) 
2 L PBS 
2 mL (1000 U / mL) heparin sodium solution (Sigma) 
10 % paraformaldehyde (2 L) 
Prepare under fume hood and store at 4 °C 
1.6 mL dH2O (heat to ~70 °C) 
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200 g paraformadehyde (dissolve in water) 
1 mL NaOH (to aid dissolution) 
2 L dH2O 
Cool solution to room temperature, titrate to pH to 7.4 with HCl and/or NaOH, filter 
and store at 4 °C. 
4 % Paraformaldehyde (2 L) 
Prepare under hood, make immediately before use and store at 4°C 
1 L 0.2 M PB 
0.8 L 10 % paraformaldehyde 
Top up to 2 L with dH2O 
30 % Sucrose solution (2 L) 
600g sucrose 
2 L 0.1 M PBS 
1 M Sodium hydroxide (NaOH) (2 L) 
50 g sodium hydroxide pellets 
Dissolve to 2 L with dH2O 
 
3.5.2 Immunostaining 
The mounted sections sections were washed in PBS (washing was performed 3 times 
for 5 minutes). Endogenous peroxidase activity may be found in many tissues, for 
example, due to the presence of red blood cells and, therefore, sections were 
quenched of peroxidise activity by pre-treatment in 0.3 % hydrogen peroxide / 70 % 
methanol in 0.1 M PBS for 30 minutes, and subsequently washed in PBS. Sections 
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were then incubated with a 3 % blocking solution for 30 minutes to suppress non-
specific binding, followed by washing. Sections were incubated with the primary 
antibody diluted in 1 % goat serum in PBS-T) overnight for 16 hours at 4 °C, followed 
by washing. To test for the specificity of the antibodies used, control slides were 
incubated with 1 % goat serum in PBS-T only, without a primary antibody present. 
Sections were then incubated with a biotinylated secondary antibody. 
 
3.5.2.1 Cleaved caspase-3 staining 
Activation of caspase-3 associated with apoptosis was established in neonatal model 
of acute neuron al injury. Thus activated caspase-3 is a relevant marker of apoptosis 
and it was used throughout my project. Slices were washed in PBS then quenched in 
a solution of 70% methanol and 0.3% hydrogen peroxide (H2O2) for 30 minutes. 
Slices were washed again in PBS, with 3 changes, and incubated in 3% blocking 
solution (PBST(PBS containing 0.3% Triton-X (Promega corporation, Madison,WI)), 
and 1% normal goat serum (NGS) (Vector Laboratories Inc.,Burlingame,CA) for 1 
hours at room temperature. After overnight incubation at 4°C with rabbit anti-
cleaved caspase-3 antibody (1:1500) (New England Biolabs, Hertfordshire,UK) in 
blocking serum the sections were washed 3 times in PBST and incubated with 
biotinylated secondary antibody (1:200 goat anti-rabbit IgG antibody)(Chemicon 
International, Temecula, CA) for 1 hour at room temperature. Following a further 3 
washes in PBST, sections were incubated in freshly prepared ABC (Avidin-Biotin-
peroxidase Complex) solution from a Vectastain ABC kit ( Vector Laboratories Inc., 
Burlingame, CA , USA) for 1 hour. ABC solution was removed with PBS and fresh 3, 
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3’- diamino-benzidine (DAB) solution (distilled water, buffer, DAB stock, H2O2 and 
nickel solution from a peroxidise substrate kit) solution from a peroxidise substrate 
kit) (Vector Laboratories Inc. Burlinggame, CA)) added. Sections were immersed for 6 
minutes and immediately washed 3 times with PBS to end staining, followed by 
washes in double distilled water. Slices were then mounted onto Super Plus-coated 
glass slides, (VWR Intrenational, Lutterworth, UK) utilising the floating technique. 
Once mounted, thesections were dehydrated in 95% alcohol then 100% alcohol for 
10 minute, followed by xylene. Vectamount was utilised to mount the cover glass 
prior to light microscope. 
 
3.5.2.2 c-Fos staining 
Slices were washed in PBS then quenched in a solution of 70% methanol and 0.3% 
hydrogen peroxide (H2O2) for 30 minutes. Slices were washed again in PBS, with 
three changes, and incubated in 3% blocking solution (PBST(PBS containing 0.3% 
Triton-X (Promega corporation, Madison,WI)), and  1% normal donkey serum (NDS) 
(Vector Laboratories Inc.,Burlingame,CA) for 1 hours at room temperature. After 
overnight incubation at 4°C with goat anti-c-fos antibody (1:1500) (New England 
Biolabs, Hertfordshire,UK) in blocking serum the sections were washed 3 times in 
PBST and incubated with biotinylated secondary antibody (1:200 donkey anti-goat 
IgG antibody)(Chemicon International, Temecula, CA) for 1 hour at room 
temperature. Following a further 3 washes in PBST, sections were incubated in 
freshly prepared ABC (Avidin-Biotin-peroxidase Complex) solution from a Vectastain 
ABC kit (Vector Laboratories Inc., Burlingame, CA , USA) for 1 hour. ABC solution was 
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removed with PBS and fresh 3, 3’- diamino-benzidine (DAB) solution (distilled water, 
buffer, DAB stock, H2O2 and nickel solution from a peroxidise substrate kit) solution 
from a peroxidise substrate kit) (Vector Laboratories Inc. Burlinggame, CA)) added. 
Sections were immersed for 6 minutes and immediately washed 3 times with PBS to 
end staining; this was followed by washes in distilled water. Slices were then 
mounted onto Super Plus-coated glass slides, (VWR Intrenational, Lutterworth, UK) 
utilising the floating technique. Once mounted, the sections were dehydrated in 95% 
alcohol then 100% alcohol for 10 minute, followed by xylene. Vectamount was 
utilised to mount the cover glass prior to light microscope.  
 
3.5.2.3 Fluorence double stainning 
Double-labelling fluorescent immunohistochemistry was used in this study. Both 
caspase-3 and c-Fos were stained. This staining technique has been shown to be 
effective (Mason et al. 2000; Negoescu et al. 1994) and has been commonly used for 
visualization of two antigens in the same tissue sections in many studies (Wu et al. 
2005; Taatjes et al. 2007; Dürr et al. 2007 ). The whole staining process in this study 
was conducted at room temperature.  
Step 1. Caspase-3 immunofluorescence staining 
Selected brain slices were washed in PBS for minimal 30 minutes, then incubated in 
10% normal goat serum (NGS, Bioclear) diluted in PBST (0.3% Triton X-100 (Promega 
corporation, Madison,WI) in PBS) for 1 h. After that, sections were incubated 
overnight with rabbit anti-cleaved caspase-3 monoclonal antibody (1:2500, Cell 
Signalling) diluted in 1% NGS in PBST. The next day, sections were washed in PBS (x3, 
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10 mins each) and incubated 1 hour with a CyTM3 –conjugated goat-anti-rabbit 
secondary antibodies (1:200, IgG, Jackson ImmunoResearch) diluted in 1% NGS in 
PBST for two hrs. Sections were next washed in PBS (x3, 10mins each).  
Step 2. c-Fos immunofluorescence staining anti-c-Fos antibody (1:1500) (New 
England Biolabs, Hertfordshire, UK). Selected brain slices were washed in PBS for 
minimal 30 minutes, then incubated in 10% normal donkey serum (NDS, Bioclear) 
diluted in PBST (0.3% Triton X-100 (Promega corporation, Madison,WI) in PBS) for 1 
h. After that, Sections were incubated for 1 h in 1:200 biotinylated donkey anti-
mouse secondary antibodies (IgG, Millipore) followed by 1 h in streptavidin Alexa 
Fluor 488.  
  
3.5.3 Quantification 
The number of DAB stained, (black) degenerated neurons expressing caspase-3 
within the cortex or hippocampus was counted in 3 anonymous sections in each 
animal, -3 to -4 mm from bregma. Neuronal cells exhibiting intense black staining of 
the cell soma and dendritic or axonal processes were counted using a BX-60 light 
microscope (Olympus, Southall, UK) and example photomicrographs were taken with 
a Axiocam digital camera ( Zeiss, Gottingen, Germany). All parameters for imaging 
were standardised to maintain consistency. 
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3.5.4 Cresyl Violet (Nissl) Staining 
Nissl is a term used by classical cytologists for the endoplasmic reticulum.  Since all 
cells contain ER, a Nissl stain (cresyl violet) will stain all cell bodies in the brain.  The 
staining procedure consists of sequentially dipping the mounted brain slices in about 
a dozen different solutions for specified amounts of time.  An initial alcohol baths 
remove the lipids and fixative from the tissue, the sections are stained, followed by 
dehydrating the tissue in a series of alcohol baths. 
 
The staining dishes were placed in fume hood and labelled in order 95% Ethanol, 
70% Ethanol, 50% Ethanol, Distilled Water, Distilled Water, Cresyl Violet Stain, 50% 
Ethanol, 70% Acid Ethanol, 95% Ethanol, 95% Ethanol, 100% Ethanol. The slides were 
inserted into slide racks.  The slide racks were passed through the following 
sequence of baths for the appropriate time indicated: 95% Ethanol 15min, 70% 
Ethanol 1min, 50% Ethanol 1min, Distilled Water2min, Distilled Water1min, Cresyl 
Violet Stain 5min, Distilled Water 1min, 50% Ethanol 1min, 70% Acid Ethanol 2min, 
95% Ethanol 2min, 100% Ethanol 1min. 
 
3.6 Western Blotting  
3.6.1 Solutions 
Tris-Hcl solution (500 mL) 
12.1 g Trizma base 
0.5 L dH2O 
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Titrate to pH 8.0 with HCl 
Tris-buffered saline (TBS) (1 L) 
8.8 g NaCl 
50 mL Tris-HCl 
Top up to 1L with dH2O 
Tris-buffered saline with 0.05 % Tween-20 (1 L) 
8.8 g NaCl 
50 mL Tris-HCl 
Top up to 1L with dH2O 
0.5 mL Tween-20 (very viscous so add after dH2O) 
 
3.6.2 Tissue homogenisation and cytosolic and membranous protein 
separation  
Rat pups were sacrificed, the brains were immediately removed and the cortices 
separated and frozen at -80°C. Samples were then lysed in cell lysis buffer (PH7.5, 20 
mmol/L Tris-HCl, 150 mmol/L NaCl, 1 mmol/L Na2DTA, 1 mmol/L EGTA, 1% Trition, 
2.5 mmol/L sodium pyrophosphate, 1 mmol/L β-glycerophosphate, 1 mmol/L 
Na3VO4, 2 mmol/L DL-dithiothreitol, 1 mmol/L phenylmethanesulfonyl and 1 µg/ml 
leupeptin) so as to achieve a 0.2 g/ml concentration and homogenised (Polytron 
homogeniser by kinematica) on ice. The homogenised sample was centrifuged at 
3000g for 10 minutes at 4°C to remove cellular debris. The supernatant was futher 
centrifuged twice, initially at 11,000 g for 20 minutes at 4°C for western blotting of 
Bcl-2, and a second time at 20,000 g for 45 minutes at 4°C to separate cytosolic and 
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mitochondrial material for western blotting of cytosolic cytochrome c and cleaved 
caspase-3. Supernatant was stored at -80°C and protein concentration was 
determined using the Bradford Protein Assay (Bio-Ra, Herts, UK). 
 
3.6.3 Protein quantification using the Bradford assay 
Bradford dye concentrate (Bio-Rad) was diluted with double distilled water (ddH2O) 
in a 1:4 ratio respectively, following manufacturer’s instructions. To make standard 
protein samples, a known concentration of bovine serum albumin (Bio-rad) was 
serially diluted with ddH2O to make a range of concentrations from 1000, 500, 250, 
125, 12.5 and 1.25 μg / mL. On ice, 10 μL of protein samples and 10 μL of protein 
standard samples were loaded in triplicate into a 96-microwell flat-bottomed clear 
plate. Triplicates of cell lysis buffer (10 μL) were also loaded to remove its possible 
contribution to total protein concentration, and ddH2O was used as blanks. Bradford 
dye (20 μL) was pipetted into each well and left to incubate for 5 minutes. The plate 
was then placed in a spectrophotometer to measure the optical density of each 
sample at 595 nm. The standard curve created from the protein standard samples 
allowed for determination of the protein sample concentration and their subsequent 
normalisation to each other. 
 
3.6.4 Electrophoretic protein separation 
Based on the Bradford assay determination of protein concentration, protein 
samples were normalised to the same concentration and volume. Denaturing sample 
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buffer concentrate containing a tracking dye (Invitrogen) was added to the 
normalised protein samples in a 1: 3 ratio respectively and subsequently heated at 
70°C for 10 minutes. 4 - 12 % gradient Bis-Tris gels (Invitrogen) were positioned in a 
gel holder and assembled into a Western blot tank that was then filled with running 
buffer (Invitrogen). Equal volumes of normalise protein samples were then loaded 
into the wells of the gel using a long fine-tipped pipette. Each well may hold a 
maximum of 25 μL of sample; 10 μL of mouse brain or kidney with sample buffer was 
loaded per well and this contained approximately 100 μg of total protein, where as 
20 μL of cells with sample buffer were loaded per well and this contained 
approximately 60 μg of total protein. 5 μL of a biotinylated protein ladder (Cell 
Signalling Technology) was also loaded in an additional lane. The gel-loaded proteins 
were then fractionated by electrophoresis at 200 V for 35 minutes which was when 
the dye front had nearly reached the bottom of the gel. 
 
3.6.5 Electrotransfer 
The proteins separated by electrophoresis were then transferred onto a 
nitrocellulose membrane that acts as a solid support. Pre-cut nitrocellulose 
membranes, filter papers and sponges were soaked in 10 % methanol transfer buffer 
(Invitrogen) for 5 minutes before the end of the electrophoretic run. According to 
the manufacturer’s instructions, a gel and membrane sandwich was then created 
from negative to positive. Electrotransfer of proteins, from gel to nitrocellulose 
membrane as air pockets hinder the flow of electrical current, air bubbles were 
smoothed out between the gel and nitrocellulose membrane by gently pressing and 
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rolling together with a Pasteur pipette. The gel-membrane sandwich was then placed 
in a transfer box which was assembled into the Western blot tank. The transfer box 
was filled with transfer buffer and cool water was used to fill the rest of the tank to 
aid in heat dissipation. The transfer of proteins from gel onto membrane was run at 
30 V for 60 minutes. 
 
3.6.6 Immunodetection 
After electrotransfer, the nitrocellulose membrane was incubated with a blocking 
solution composed of 5 % non-fat dry milk in Tween-20-containing Tris buffered 
saline (TBS-T) for 3 hours on a gyrating shaker (Fisher Scientific) at room 
temperature. Subsequently, the blocked membrane was incubated overnight for 16 
hours at 4°C on a gyrating shaker with the relevant primary antibodies; or mouse 
monoclonal antibody, 1 : 1000 (Novus Biologicals); or rabbit polyconal antibody, 1 : 
1000, (BD Biosciences). The primary antibodies were incumbated at optimised 
dilutions in 5 % non-fat dry milk solution. After removing the antibody, 4 wash in 
TBS-T lasting 5 minutes each were performed at room temperature on a rapidly 
moving gyrating shaker. The membrane was then incubated with the appropriate 
goat-derived horseradish peroxidase-conjugated secondary antibody (Cell Signalling 
Technology) directed against the rabbit-derived primary antibodies at room 
temperature for 1.5 hours on a gyrating shaker. The secondary antibody was then 
removed and 5 washes in TBS-T lasting 5 minutes each were performed at room 
temperature on a rapidly moving gyrating shaker with an additional sixth wash for 5 
minutes in TBS without tween-20, as this detergent interferes with the 
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chemiluminescent reaction. To maximise the visualising of immunoreactive bands, 
the enhanced chemiluminescent (ECL) reagent was mixed with the accompanying 
peroxidase reagent (Lumiglo kit (Cell SignallingTechnology)) only at the very last 
minute. The membrane was then incubated for 1 minute in the ECL solution and 
then placed protein-side up between two transparent acetate sheets, with trapped 
air bubbles gently rolled out using a Pasteur pipette. The acetate-covered membrane 
was then placed inside a film cassette and in a completely dark room exposed to 
radiographic film (ECL Hyperfilm (Amersham Biosciences)) for optimised lengths of 
time. After radiographic film capture of the immunoreactive bands, the membrane 
was removed from the acetate and washed 3 times in TBS-T lasting 5 minutes each 
at room temperature on a rapidly moving gyrating shaker. The membrane was then 
subjected to the same protocol as outlined above for detection of the house-keeping 
protein, α-tubulin: it was re-blocked in blocking solution before incubation with the 
anti-α-tubulin antibody, washed, incubated with the secondary antibody, washed 
and visualised using the ECL system capture on radiographic film. The results were 
then quantified by densitometric analysis using Adobe Photoshop Elements 2.0 
software, scaled relative to the control sample, and normalised with the 
housekeeping protein α-tubulin.  
 
3.7 Organotypic hippocample slice culture  
Post-natal day 7(PND) SD rat pups (B&K Laboratories, Harlon) were provided and 
housed in a 24-hour diurnal enclosure with food and drink adlibitum. The date of 
birth for the animals was defined as 0-day-old and animals were sacrificed on PND 7 
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and 8 during synaptogenesis. The study protocol was approved by Home office (UK) 
and conforms to the United Kingdom Animals (Scientific Procedures) Act, 1986. 
 
Organotypic hippocampal slices were prepared according to the interface culture 
method as modified by (Sullivan et al, 2001). In brief, neonatal rat pups (PND9/10) 
were anaesthetised using 0.5% isoflurane until quiescent and sacrificed by 
decapitation. The brain was quickly dissected and placed in ice cooled (4°C) 
dissection solution to reduce extraction-induced ischaemia (200ml high sucrose-
glucose (HSG) solution, 64ml Hanks-balanced salt solution (HBSS) (Gibco) and 0.6ml 
Antibiotic-Antimycotic solution (AAS) (Sigma)). All stages of slice preparation were 
carried out under sterile and ice-cooled conditions.          
 
Excess tissues (cerebellum, olfactory bulbs and meninges) were removed and the 
brain cut into 400 µm saggital slices using a Mclllwain Tissue Chopper (Mickle 
Laboratory, Cambridge, UK). Under a microscope (Zeiss W-Pl 10*) and cooling light 
(KL 1500, Schott) the slices were separated using fine forceps, avoiding contact with 
the hippocampus. 
 
Slices with hippocampus were selected and placed onto 30 mm diameter semi 
porous cell culture inserts (Falcon, Becton Dickinson Labware , Millipore, Bedford, 
MA,USA).Five slices were positioned on each insert and placed in a 6-well Tissue 
Culture Tray (Multiwell TM Falcon, Becton Dickinson labware, Bedford, MA,USA) 
Growth media (1.5 ml) (made up with: 282 ml Medium Stock (Gibco/Life 
                                                                                                                                                                             Yi Shu 
Imperial College London                                                     85                                                                                    Dec 2010   
technologies), 32 ml Horse Serum,32 ml Foetal Bovine Serum and supplemented 
with 3.2 ml Glutamine and 3.2 AAS (Gibco/Sigma)) was then transferred to each well. 
 
The slices were incubated for 24 hours in humidified air at 37°C, enriched with 5% 
Carbon Dioxide to allow for recovery from the trauma induced by the extraction. The 
culture medium was replaced the following day with fresh, equilibrated medium.   
  
3.8 Trace fear conditioning  
Seven day old SD rat pups were exposed to 8% oxygen balanced with nitrogen or 
70% xenon and 30% oxygen for 2 hours. 24 hours after exposure, pups were treated 
with 70% nitrous oxide and 0.75% isoflurane for 6 hours. They were allowed to live 
up to 40 days.  They were then tested for hippocampal-dependent memory and 
learning function in a contextual fear conditioning behavioural paradigm in which:  
On the first test day, the animals received both tone and shock six times during the 
26-minute testing period (Conditioning Test); on the second day, they were exposed 
to the same environment but received neither tone nor shock for 8 minutes (Context 
Test); on the third day, they received tone three times during 18 minutes (Tone Test). 
The percentage of freezing time (Context results) and the area under curve (AUC) 
were derived from plots between the percentage freezing time and trial time in the 
Tone Test, and were used for statistical comparison (mean ± SD, n = 4-6) (Figure 3.2).    
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                            Figure 3.2 Behavioural tests –fear conditioning set up. 
                                                                                                                                                                                                                                                                                                              
3.9 Statistical analysis 
Both immunohistochemistry and western blotting results were expressed as mean ± 
standard division of the mean. Statistical analysis comprised of one way analysis of 
variance (ANOVA) with post-hoc Student Newman-Keul’s multiple comparison test. A 
p value of <0.05 was considered statistically significant. 
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CHAPTER 4   
ANESTHESIA INDUCED APOPTOSIS IN NEONATES 
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4.1 Introduction 
Clinicians have long held the illusory hope that the constellation of profound 
behavioural effects comprising general anaesthesia is entirely reversible and that the 
central nervous system (CNS) returns to its pristine state once the anaesthetic agent 
is eliminated from the active site. However, as scientists have unravelled the targets 
in the CNS which may be responsible for the production of the ephemeral state of 
general anaesthesia, they have also found that perturbation of the normal 
functioning of these targets may produce long-lasting undesirable effects.  
 
The work by Olney’s team has helped elucidate the mechanisms underlying the 
deleterious effects of alcohol on the developing brain, which is responsible for the 
development of Foetal Alcohol Syndrome (FAS) (Ikonomidou et al., 2000). Olney and 
co-workers argued that as general anaesthetic drugs acted on the same receptors as 
alcohol, they might produce similar behavioural and molecular effects as the latter. 
Indeed, Olney and his collegaues showed that exposure of a few days’ old rat pups  
to a standard anaesthetic cocktail produced similar morphologic and functional 
impairment as that seen with exposure to alcohol; these effects enhanced naturally 
occurring apoptosis (Jevtovic-Todorovic et al., 2003).  
 
Several subsequent studies have confirmed the finding that this anaesthetic cocktail 
induces apoptotic neurodegeneration (Yon et al., 2005; Yon et al., 2006) and 
demonstrated that various other anaesthetic agents and cocktails also induce the 
same response when administered post-natally (Urraca et al., 2006; Takadera et al., 
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2006; Young et al., 2005). As for this evidence, I postulate that common anaesthetics 
my also induce neurodegeneration in neonates. So, firstly, I use clinic anaesthetics in 
neonate animal to looking for neurodegeneration evidence. 
 
4.2 Method  
4.2.1 Gas expouse 
Seven day old Sprague-Dawley rats were exposed to oxygen along with one of 
several gas combinations (nitrogen, 70% nitrous oxide, 0.75% isoflurane, 70% N2O + 
0.75% isoflurane,) for 6 hours (n = 3-5/group).                        
Naїve 
ISO(0.75%) 6 hours 
N2O (70%) 6 hours 
N2O(70%) +ISO(0.75%) 6 hours 
Table 1. Seven day old Sprague-Dawley rats were exposed to different conditions presented 
above. 
 
4.2.2 Immunohistochemistry 
In vivo 
The rats were sacrificed after anaesthesia, and their brains processed to assess the 
severity of apoptosis, caspase 3 as a marker. With the immunostaining of the brain 
slices was measured.  
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In vitro 
Organotypic hippocampal slices were derived from 8/9 day post-natal C57B6 mice 
pups. The slices were treated as in the in vivo preparations. The slices were cryostat 
after 24 hours and immunohistochemistry of caspase-3, a member of the apoptotic 
common pathway, was performed. Photomicrographs were taken, CA1 and CA3 
subregions were manually outlined and the number of caspase-3 positive cells 
counted.  
 
4.2.3 Western Blotting 
Gas delivery occurred for 6 hours after which the animals were immediately 
sacrificed and their cortices removed for western blotting of caspase-3, -8, -9, 
cytochrome c. Results were normalised to the control and the housekeeping protein 
α-tubulin with densitometric analysis. 
 
4.3 Results 
4.3.1. Cortical and hippocampus activated Caspase-3 
Neuronal cells exhibiting caspase-3 activation were readily distinguishable from the 
background as black cell body and axons.  The staining established the level of 
background level of cortical activated capase-3 in rats exposed to air as 19.3 ± 6.4 
(mean ± SD), n = 4 (Fig. 4.1).  Administration of 70% N2O in oxygen did not induce 
any significant increase in caspase-3 positive cells compared to naïve (22.5 ± 5.9, n = 
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3; p>0.05 vs Naïve) whereas administration of 0.75% isoflurane in oxygen / air 
mixture produced a moderate increase in level of activated caspase-3 staining (76.5 
± 11.4, n = 5; p < 0.01 vs Naïve) (Figure 4.1). The combination of 70% N2O and 
isoflurane in oxygen significantly increased the number of caspase-3 positive cells 
compared with Naïve (232 ± 20 p < 0.01 vs Naïve) (Figure 4.1.A and Figure 4.1.B 
respectively). 
 
The staining established the level of background level of activated capase-3 
activation in hippocampus in rats exposed to air as 5.2 ± 1.8 (mean ± SD), n = 4 (Fig. 
4.1).  70% N2O in oxygen did not induced any significant increase in caspase-3 
positive cells compared to naïve (3.7 ± 1.4, n = 3; p>0.05 vs Naïve) whereas 
administration of 0.75% isoflurane in an oxygen / air mixture produced a moderate 
increase in the level of activated caspase-3 staining (22.1 ± 9.6, n = 5; p < 0.01 vs 
Naïve) (Figure 4.1).The combination of 70% N2O and 0.75% isoflurane in oxygen 
significantly increased the number of caspase-3 positive cells compare with Naïve 
(34.8 ± 20.2 p < 0.01 vs Naïve) (Figure 4.1.D) (Figure 4.1.E). 
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Figure 4.1 Caspase 3 expressions induced by anesthetics in vivo.  
Apoptotic neurodegeneration induced by anesthetics (75% nitrous oxide (N2O), 0.75% isoflurane 
(Iso), 0.75% Iso plus 75% or 35% N2O) as measured with cleaved caspase-3 immunostaining in 
the cortex and the hippocampus of day 7 neonatal rats. (A) Photomicrograph of the cortex of a 
neonatal rat exposed to 0.75% Iso plus 75% N2O. (B) Photomicrograph of the cortex of a 
neonatal rat in Naïve group. (C) Data (mean ± SD, n = 5 or 6) of caspase 3–positive cells in the 
cortex from all treatment groups. (D) Photomicrograph of the hippocampus of a neonatal rat 
exposed to 0.75% Iso plus 75% N2O. (E) Photomicrograph of the hippocampus of a neonatal rat 
in Naïve group. (F) Data (mean ± SD, n = 5 or 6) of caspase 3–positive cells in the hippocampus 
from all treatment groups. *P < 0.01, ** P < 0.001 versus air. Scale bar = 200 µm. 
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4.3.2 Caspase 3 immunohistochemistry in vitro 
Neuronal cells expressing cleaved caspase 3 were readily distinguishable in general, 
exhibiting an intense black staining of the cell soma and dendrites (Figure 4.2). The 
baseline background level of apoptosis in the negative control has a mean of 28.0 ± 
8.0 (n = 5), which corresponded to cell death as a result of trauma due to dissection 
of the tissues and physiological apoptosis during synaptogenesis. Exposure to the 
individual agents nitrous oxide and isoflurane, resulted in statistically significant 
mean increase in cell death of 39.0 ± 8.0 (n=5) and 45.0 ± 9.0 (n=5), respectively 
compared to control (p < 0.01). Combination of isoflurane with nitrous oxide 
resulted in a statistically significant increase in caspase 3 positive cells (60.0 ± 11.0, 
n=4, p < 0.01) (Figure 4.2).  
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Figure 4.2 Caspase 3 expression induced by anaesthetics in vitro. 
Exposure hippocampus slices in vivo to the individual agents isoflurane and nitrous oxide, 
resulted in a statistically significant (p < 0.01) mean increase in cell death above control levels of 
40 ± 13 and 39 ± 15, respectively. Xenon and Iso combination (29 ±17) have no effect compared 
with air( 28±11). Combination of isoflurane with nitrous oxide resulted in a statistically significant 
increase in caspase 3 positive cells (40.03 ± 11.71, n=6, p < 0.01). 
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4.3.3.1 Immunoblotting of Caspase-3 expression  
To investigate the involvement of the common apoptotic pathway, the expression of 
cleaved caspase-3 protein was measured. In agreement with previous studies using 
immunohistochemistry (Urraca et al., 2006), immunoblotting indicates that 70% N2O 
alone caused a significant increase in the expression of caspase-3 (1.00 ± 0.03 p>0.05 
vs air) (mean ± SD) compared to the baseline. 0.75% isoflurane alone caused a slight 
increase in the expression of caspase-3 (1.31 ± 0.08, p>0.05 vs air), but when it was 
combined with 70% N2O it caused a significant increase in the latter (3.43 ± 1.34, 
p<0.05 vs air) (Figure 4.3 A). 
 
4.3.3.2 Immunoblotting of cytosolic cytochrome c expression 
One of the key markers of intrinsic pathway activation is the release of cytochrome c 
from the mitochondria into the cytosol. 0.75% isoflurane alone caused no change in 
cytosolic cytochrome C expression compared to baseline (0.91 ± 0.08, p> 0.05 vs air). 
However, 70% N2O produced a significant increase in cytosolic cytochrome c (3.36 ± 
1.33, p<0.05 vs air). Combination of 0.75% isoflurane with 70% N2O induced a 
moderate increase in cytosolic cytochrome c expression (1.10 ± 0.31, p>0.05 vs air) 
(Figure 4.3 B). 
 
 
 
                                                                                                                                                                             Yi Shu 
Imperial College London                                                     96                                                                                    Dec 2010   
4.3.3.3Immunoblotting of Caspase-9 expression 
Cleaved caspase-9 which is downstream of cytochrome c release was also 
investigated. 0.75% isoflurane in an oxygen / air misture did not cause any significant 
change in caspase-9 expression when compared to control (0.94 ± 0.10, P >0.05). 
Both 70% N2O in oxygen and  70% N2O in oxygen combinated with 0.75% isoflurane 
produced increases in caspase-9 expression (1.13 ± 0.08 and 1.49 ± 0.51 respectively) 
but these were not statistically significant (Figure 4.3 C).  
 
4.3.3.4 Immunoblotting of Caspase-8 expression 
The expression of cleaved caspase-8 was used as a marker of activation of the 
extrinsic apoptotic pathway. Neither 0.75% isoflurane alone nor the combination of 
70% N2O with 0.75% isoflurane produced any change in expression of cleaved 
caspase-8 expression compared to the baseline (0.96 ± 0.18 and 0.92 ± 0.24 
respectively). However, both 70% N2O alone and when combined with 0.75% 
isoflurane produced moderate increases in caspase-8 expression (1.05 ± 0.21 and 
1.27 ± 0.29 respectively) but these were not statistically significant (Figure 4.3 D).  
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Figure 4.3 Apoptotic neurodegeneration induced by anesthetics in vivo. 
Effects of anesthetic exposure (75% nitrous oxide (N2O), 0.75% isoflurane (Iso], 0.75% Iso plus 
75% N2O) for 6 h in day 7 rats on expression of signaling components of apoptotic pathways. 
Representative immunoblotting images and mean ± SD (n = 4) of expression of caspase 3 (A), 
cytosolic cytochrome c (B), caspase 9 (C), and caspase 8 (D) induced by each anaesthetic 
exposure as reflected by the band density normalized with alpha-tubulin. Control = air exposure; 
Cyt. C = cytochrome c . * P< 0.05, ** P < 0.01 versus control. 
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4.4 Discussion 
Neuronal cell death can be induced in several ways and these can be identified by 
their typical morphological appearances (Cozzolino et al., 2004). Broadly, although 
currently it is still debated as to whether these represent two distinct processes or 
whether they are just two poles at either end of a continuum, they can be classified 
as either apoptotic or excitotoxic neuronal degeneration (Yakovlev et al., 2001; 
Yakovlev et al., 2004). Anaesthetic drugs induced neurodegeneration during the 
period of synaptogenesis is probably mediated via the apoptotic pathway and this 
may be attributed to their excessive depression of neuronal activity (Cozzolino et al 
2004). 
 
There is increasing evidence supporting the view that intracellular calcium (Ca
2+
) 
transients are very important for maintaining and protecting healthy synapses 
(Papadia et al., 2005); it is therefore not surprising that blockade of NMDA subtype 
of glutamate receptors (which is a main source of these Ca
2+
 ions) during the critical 
period of synaptogenesis can result in neuronal damage.  Inhibiting Ca
2+
 entry 
through synaptic NMDA receptors reduces cAMP response element binding (CREB) 
activity and this has numerous repercussions including diminished neurotrophin 
expression (e.g. BDNF) (Hansen et al., 2004;  Dzietko et al., 2004). It removes 
proteins which are essential for the survival of neurons and the growth of synapses 
and hence lead to neuronal death (Huang et al., 2001). Furthermore, NMDA 
antagonists cause a reduction of extracellular signal-related protein kinase 1/2 
(ERK1/2) catalytic activity, and the transcriptional reduction of the anti-apoptotic 
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protein Bcl2, all of which contribute to a pro-apoptotic environment (Asimiadou et 
al., 2005; Bittigau et al., 2002). 
 
However, NMDA antagonists are not the only culprits, as exposure to isoflurane 
alone (a GABAA mimetic) may also induce apoptotic neurodegeneration (Hardingham 
et al., 2005). Activation of GABAA receptors during certain periods of the 
development of the CNS has a depolarising instead of a hyperpolarizing effect on 
neural membranes (Wang, et al., 2008). However, in line with the importance of Ca
2+
 
transients and with recent suggestions that proper balance between excitation and 
inhibition may be critical for cell survival in the CNS several authors (Hardingham et 
al., 2003; Xu et al., 2000) have suggested that the primary inhibitory brain 
neurotransmitter GABA produced its neurotoxic by inhibiting neuronal 
depolarisation and consequently depressed Ca
2+
 influx levels resulting in reduced 
synaptic activity and thus increased the probability of neuronal death (Xu et al., 
2000). 
 
The toxic effects produced as a result of drugs interacting with GABAA and/or NMDA 
subtypes of glutamate receptors have been demonstrated with numerous agents 
(Ikonomidou et al., 2000; Ikonomidou et al., 1999; Bittigau et al., 2002). There is 
another interesting finding in the result that N2O alone can also induce caspase 
expression in vivo. This is relevent to clinic applications, because 70%N2O is common 
used in human neonatal surgery or delivery period nowdays. I think it is deserve 
more to detect the pathway of  the  damage.  
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CHAPTER 5                          
ANESTHESIA PROVOKES SPINAL CORD INJURY IN 
NEONATAL RATS 
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5.1 Introduction 
Anaesthesia induces neuroapoptosis throughout the brain in the neonatal rat; this 
discussed in chapter 4 where rats received either 70% N2O or 0.75% ISO in oxygen 
and air mixture or both anaesthetic drugs.  The current hypothesis suggests that 
inhibition of synaptic activity during the critical period of synaptogenesis results in a 
reduction in the release of neurotrophic factors at a time when neurons are busy 
establishing new synaptic contacts and lack of such contact will trigger apoptotic 
neuronal degeneration in the cells concerned as they are thought to be not essential 
(Antognini et al., 2002; Rampil et al., 1993). The mechanism of apoptotic injury and 
the extent of its spatial distribution in central nervous system remain largely 
unknown.  
 
In this chapter, I shall therefore focus on the spinal cord as a possible site of injury 
produced by isoflurane and nitrous oxide anaesthesia drugs administered together in 
a combination similar to the one that produced robust neuropaoptosis in neonatal 
brain (Jevtovic-Todorovic et al., 2003; Antognini et al., 1993; Rampil et al., 1993). I 
postulate that anaesthetic treatment would not induce apoptosis in the spinal cord 
of neonatal rat.  
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5.2 Method 
Seven day old Sprague-Dawley rats were exposed to oxygen along with 70% N2O + 
0.75% isoflurane for 6 hours (n = 3-5/group) (Table 2). Three animals per group were 
sacrificed at the end of gas exposure; they were perfused transcardially with 
heparinised saline followed by paraformaldehyde 4% in 0.1M buffer. The spinal 
cords after they were removed by pneumatic injection were stored overnight at 4
o
C 
in paraformaldehyde and then transferred to sucrose solution (30%) with phosphate 
buffer and sodium azide 1%. They were kept refrigerated until they were sectioned 
at the lumbar level (Cheng et al., 2000). The sections were then incubated at 4
o
C 
with rabbit anti-cleaved caspase-3 (1:2500; New England Biolab, Hitchin, UK).  The 
numbers of caspase-3 immunoreactive neurons were counted in four lumbar spinal 
cord sections per animal by an investigator blinded to the experimental protocol.  
Naїve 
N2O(70%) +ISO(0.75%) 6 hours 
 
Table 2. Seven day old Sprague-Dawley rats were exposed to different conditions presented 
above. 
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5.3 Results  
Anaesthesia with nitrous oxide and isoflurane for 6 hours increased the number of 
caspase-3 positive cells relative to air exposure (p < 0.01, n = 3 per group) (Figure 
5.1).  
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Figure 5.1 Apoptotic neurodegeneration induced by anesthetics in spinal cord 
Apoptotic neurodegeneration induced by 75% Nitrous oxide + 0.75% isoflurane as measured 
with caspase-3 immunostaining in the lumbar enlargement of spinal cord of 7-day-old neonatal 
rats (n = 3 per group). A, Air control; B, 75% Nitrous oxide + 0.75% isoflurane in oxygen; C, Mean 
(mean ± SD; n = 3). Black arrows = caspase 3 positive cells.  
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5.4 Discussion  
The results demonstrate that exposure to an isoflurane-nitrous oxide based 
anaesthetic provokes apoptosis in the neonatal rat spinal cord as evidenced by the 
increase in cleaved-caspase 3 immunoreactivity. Furthermore, the current work, 
described here, demonstrates that the apoptotic injury is distributed over a wider 
area in the central nervous system than has previously been reported in other 
studies (Antognini et al., 1993; Antognini et al., 2002; Rampil et al., 1993; Rampil et 
al., 1994; De Jong and Wagman, 1968). 
 
In previous studies, I used caspase-3 immunohistochemistry to identify the apoptotic 
injury as it is an early marker of cellular apoptosis and also it is considered to be a 
reliable marker for apoptosis in previously published studies where anesthetic drug 
induced injury in the brain were evaluated (Jevtovic-Todorovic et al., 2003). 
Therefore, in this study, we use caspase- 3 immunohistochemistry technique to 
identify neuronal apoptosis in the spinal cord. 
 
The observed vulnerability of the ventral horn of the spinal cord to anaesthetic injury 
is in keeping with the ability of anaesthetic agents in suppressing neurotransmission 
in this region (Paxinos and Watson, 1998). Previous studies suggest that anaesthetic 
drugs must produce adequate depth of anaesthesia to produce their neurotoxic 
effects in the spinal cord (Antognini et al., 2002). This may indicate that the same 
mechanisms which produce the state of general anaesthesia by anaesthetic drugs 
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may also explain the apoptosis-induced cell death by these drugs (Antognini et al., 
2002). Indeed, escalating doses of isoflurane provoke increasing apoptosis in the 
brain (Jevtovic-Todorovic et al., 2003).  
 
However, it is also possible that both anaesthetic agents inhibit the apoptotic injury 
and increase the depth of anaesthesia through differing mechanisms. Nonetheless, 
the data presented here appear to support further the link between the ability for 
anaesthetic agents in inhibiting neuronal activity and provoking cellular death. 
 
Anaesthetic-induced neurodegeneration in the spinal cord may have clinical 
significance despite this result uncover a functional endpoint for the injury. A fairly 
recent randomized controlled trial (the GAS study) was initiated to compare the 
effects of exposure of regional to general anaesthesia on neurodevelopment in rats 
during the neonatal period (Devor et al., 2001). The data suggest that the subjects in 
both arms of the trial may be vulnerable to spinal cord injury. The potential 
vulnerability of the neonatal spinal cord to neuroapoptosis induced by anaesthetic 
agents was, hitherto, unknown. Thus clinical trials may need to consider the pro-
apoptotic potential of both general (Antognini et al., 1993; Antogini et al., 2002; 
Rampil et al., 1993; Rampil et al., 1994; De Jong et al., 1968) as well as local 
anaesthetics (Stabernack et al., 2005; Kingery et al., 2002) as the anaesthetic injury 
in the neonate is both dose- and duration-dependent, the potent inhibitory effects 
on neurotransmission of regional anaesthesia may also induce neuroapoptosis in the 
spinal cord. Indeed, because of the intensity and duration of action of regional 
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anaesthetics, the injury in the spinal cord after spinal anaesthesia may be more 
pronounced than after general anaesthesia. Functional neurodevelopmental 
assessments following regional anaesthetic treatment will also be required to 
address the potential impact of the findings on humans. As the methods employed 
in preclinical studies may be insensitive to the subtle changes induced in the 
developing nervous system in humans, future clinical trials should also consider 
investigation of sensory and motor responses during development of humans 
following exposure to general anaesthetic drugs in the neonatal period.  
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CHAPTER 6                               
ANAESTHESIA-INDUCED NEURODEGENERATION IN 
DIFFERENT REGIONS OF THE DEVELOPING BRAIN 
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6.1 Introduction 
Neurons are the principle cells in the central nervous system; they can be classified, 
based on the neurotransmitters they release, for example glutamatergic, GABAergic, 
dopaminergic and cholinergic neurons (Steven and Hyman 2005). Neocortex and 
hippocampus (including cingulate cortex) are crucial brain structures involved in 
learning and memory (Squire et al., 2004; Wiltgen et al., 2004; Frankland and 
Bontempi, 2005; Blum et al., 2006) and they have mainly glutamatergic and 
GABAergic neurons (Sem'yanov, 2005; DeFelipe et al., 2002). These two types of 
neurones are widely distributed in the CNS (Foster and Kemp, 2006). Acetylcholine 
(ACh) is also critical for cognitive processing, arousal, and for attention in the brain 
(Karczmar 2010). Based on behavioural studies conducted in animals so far, general 
anaesthetics are believed to elicit a hippocampus-dependent learning deficit (Sall et 
al., 2009; Satomoto et al., 2009).  
 
In humans, memory deficits associated with Alzheimer’s disease and normal aging 
can be attributed to degeneration of cholinergic neurons in the basal forebrain 
region, particularly in the nucleus basalis of Meynert (Muir, 1997; Wu et al., 2005). 
Within the basal forebrain cholinergic system, cholinergic neurons primarily project 
to the hippocampus and neocortex (Phillis 2005). Isoflurane suppresses the release 
of Ach in these two brain regions in rats (Shichino et al., 1998; Whittington and Virag, 
2006), the mechanism by which this is achieved remains unknown; such an effect 
may be due to anaesthesia-induced cholinergic neuron death in the basal forebrain.   
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Up to now, most research studies have been conducted on catecholamine neuro-
transmitters. More recently, an increasing number of studies have been published 
supporting the view that dopamine pathways play an important role in learning and 
memory and they also have a significant impact on cognition and emotion (Packard 
and Knowlton, 2002; Jay, 2003; González and Feria, 2008; Olvera-Cortés et al., 2008; 
Nieoullon and Coquerel, 2003). Neurochemically the hippocampus, neocortex and 
striatum receive midbrain dopaminergic projections mainly from the substantia nigra 
with some from the ventral tegmental area (Björklund and Dunnett 2007). The 
release of dopamine in these regions can enhance long-term potentiation (Jay, 2003). 
In Parkinson’s disease, cell death in the substantia nigra leads to a reduction in 
dopaminergic output (Schapira, 2009) and behavioural studies in patients with 
Parkinson’s disease have demonstrated that the circuitry required for learning the 
stimulus-response associations is disrupted (Knowlton et al., 1996).  
 
Furthermore, several in vivo studies have indicated that anaesthetic drugs may have 
an impact on dopaminergic neurons. For example, it has been shown that the level 
of dopamine in the striatum rises following anaesthetic exposure (Adachi et al., 2000; 
Adachi et al., 2005) and general anaesthetics with the neurotoxin, 6-
hydroxydopamine could significantly increase the extent of nigrostriatal 
dopaminergic neuronal loss (Datla et al., 2006). Therefore, we hypothesise that 
anaesthetic exposure during the period of rapid synaptogenisis may lead to an 
increase in cell death in the four types of neurons described above in specific brain 
regions, which could contribute to learning and memory deficits observed later on in 
life.  
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Animal studies have shown that anaesthetic drugs induced neuronal cell death is 
mediated via the apoptotic pathway (Ma et al., 2007; Sanders et al., 2008; Johnson 
et al., 2008; Wei et al., 2008; Lu et al., 2006). The study, described in this chapter, 
was designed to investigate whether gaseous or volatile anaesthetics (70% nitrous 
oxide and 0.75% isoflurane) would induce cell apoptosis in glutamatergic, GABAergic, 
dopaminergic and cholinergic neurones in specific brain regions of 7-day-old rats. 
 
6.2 Method 
6.2.1 In vivo experiment    
Separate cohorts (n= 4-6 per group) of 7-day- old littermate Sprague-Dawley rat 
pups were randomly assigned to two groups: Naïve (room air); Anaesthetics (70% 
nitrous oxide and 0.75% isoflurane for 6 hrs) (Table 2). 
Naїve 
N2O(70%) +ISO(0.75%) 6 hours 
 
Table 3. Seven day old Sprague-Dawley rats were exposed to different conditions presented 
above. 
 
The remaining gas constituents were 25% oxygen in groups 2-6 and balanced with 
nitrogen where necessary. According to the Animals Act, surgical incision and 
formalin injection were conducted 10 minutes after rats were anaesthetised with 
70% nitrous oxide and 0.75% isoflurane and rats in group 3 and group 5 were then 
exposed to room air rather than anaesthetic agents for 6 hours.  Naive rats were 
placed in exposure chambers for 6 hr without exposure to anaesthetic agents or 
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noxious stimuli but otherwise similar conditions as those for the other studied 
groups were maintained. 
 
For glutamatergic and GABAergic neurons, the cingulate cortex (Bregma 2.04-
1.08mm) and CA1 subarea of the hippocampus (Bregma -5.40mm) were examined.  
 
For cholinergic neurones, the entire basal forebrain was examined (Bregma 0.60mm). 
 
For dopaminergic neurones, the substantial nigra was examined (Bregma -5.04mm).   
 
6.2.2 Double-labelling fluorescent immunohistochemistry  
Double-labelling fluorescent immunohistochemistry was used in this study. Both 
caspase-3 and one specific neuronal-cell-type marker were stained. This staining 
technique has been shown to be effective (Mason et al., 2000; Negoescu et al., 1994) 
and is being used commonly in many studies for visualization of two antigens in the 
same tissue sections (Wu et al., 2005; Taatjes et al., 2007; Dürr et al., 2007).  
 
The whole staining process in this study was conducted at the room temperature.  
 
6.2.2.1. Caspase-3 immunofluorescence staining 
Selected brain slices were washed in PBS for minimal 30 minutes, then incubated in 
10% normal goat serum (NGS, Bioclear) diluted in PBST (0.3% Triton X-100 (Promega 
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corporation, Madison, WI) in PBS) for 1 h. After that, sections were incubated 
overnight with rabbit anti-cleaved caspase-3 monoclonal antibody (1:2500, Cell 
Signalling) diluted in 1% NGS in PBST. The next day, sections were washed in PBS (x3, 
10mins each) and incubated for 1 hour with a CyTM3-conjugated goat-anti-rabbit 
secondary antibodies (1:200,IgG, Jackson ImmunoResearch) diluted in 1% NGS in 
PBST for two hrs. Sections were next washed in PBS (x3, 10mins each).  
 
6.2.2.2. Glutamatergic, GABA-ergic, cholinergic and dopaminergic 
neuron immunofluorescence staining  
Immediately after the caspase-3 immunofluorescence staining, all sections were 
incubated in 10% normal donkey serum (NDS, Millipore) diluted in PBST for 1 h. Then 
sections containing different brain bregma regions were incubated with different 
primary antibodies (see below). Primary and secondary antibodies were diluted in 
1% NDS in PBST. The fluorescent probe: streptavidin Alexa Fluor 488 (1:1000, 
Invitrogen) was diluted in PBST. Between incubations, sections were washed 3 x10 
min in PBS.  
 
For glutamatergic, GABAergic and dopaminergic neurons, sections were incubated in 
mouse anti-vesicular glutamate transporter 1 (vGLUT1) (1:100, Millipore), mouse 
anti-glutamic acid decarboxylase-67 (GAD67) (1:5000, Sigma) and mouse anti-
dopamine (1:100, Millipore) monoclonal antibodies overnight respectively. 
Thereafter, sections were incubated for 1 h in 1:200 biotinylated donkey anti-mouse 
secondary antibodies (IgG, Millipore) followed by streptavidin Alexa Fluor 488 for 1 h.  
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For cholinergic neurons, sections were incubated in goat anti-choline 
acetyltransferase (ChAT) polyclonal antibodies (1:200, Millipore) overnight. Sections 
were next incubated for 1 h in 1:200 biotinylated donkey anti-goat secondary 
antibodies (IgG, Millipore) followed by 1 h in streptavidin Alexa Fluor 488.  
 
 
6.3 Results 
6.3.1 The neuronal types involved in anaesthesia-induced 
neuroapoptosis  
Cingulate cortex: 30 % and 37 % of all apoptotic cells were GABAergic and 
glutamatergic neurons respectively (Total number of caspase-3 positive cells in the A 
alone group: 30; GAD67/caspase-3 co-expressing cells: 9; VGLUT1/caspase-3 co-
expressing cells: 11) (Figure 6.1). CA1 subarea of hippocampus: 54 % and 14 % of all 
apoptotic cells were GABAergic and glutamatergic neurons respectively (Total 
number of caspase-3 positive cells in the A alone group: 56; GAD67/caspase-3 co-
expressing cells: 30; VGLUT1/caspase-3 co-expressing cells: 8) (Figure 6.2). 
Substantia nigra: 22 % of all apoptotic cells were dopaminergic neurons (Total No. of 
caspase-3 positive cells in the A alone group: 73; dopamine/caspase-3 co-expressing 
cells: 16) (Figure 6.3). Basal forebrain: none of the apoptotic cells were cholinergic 
neurons (Total No. of caspase-3 positive cells in the A alone group: 7; ChAT/caspase-
3 co-expressing cells: 0) (Figure 6.4). 
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Figure 6.1 GAD67/caspase-3 co-expressing and VGLUT1/caspase-3 co-expressing cells in 
cingulate cortex 
Separate cohorts (n= 4-6 per group) of 7-day- old, littermate Sprague-Dawley rat pups were 
randomly assigned to two groups: Naïve (room air) and Anaesthetics (70% nitrous oxide and 
0.75% isoflurane for 6 hrs). The cingulate cortex of hippocampus was sessioned and slices were 
stained with anti-caspase 3 antibodies together with anti- vesicular glutamate transporter 1 
(vGLUT1) antibodies (staining GABAergic neurons or mouse anti-glutamic acid decarboxylase-67 
(GAD67) antibodies (staining glutamatergic neurons). The percentage of caspase 3 positive cells 
in GABAergic neurons, the percentage of caspase 3 positive cells in glutamatergic neurons and 
the percentage of caspase 3 positive cells in other cells was calculated. 
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Figure 6.2 GAD67/caspase-3 co-expressing and VGLUT1/caspase-3 co-expressing cells in 
hippocampus 
Separate cohorts (n= 4-6 per group) of 7-day- old, littermate Sprague-Dawley rat pups were 
randomly assigned to two groups: Naïve (room air) and Anaesthetics (70% nitrous oxide and 
0.75% isoflurane for 6 hrs). The CA1 subarea of hippocampus was sessioned and slices were 
stained with anti-caspase 3 antibodies together with anti- vesicular glutamate transporter 1 
(vGLUT1) antibodies (staining GABAergic neurons or mouse anti-glutamic acid decarboxylase-67 
(GAD67) antibodies (staining glutamatergic neurons). The percentage of caspase 3 positive cells 
in GABAergic neurons, the percentage of caspase 3 positive cells in glutamatergic neurons and 
the percentage of caspase 3 positive cells in other cells was calculated. 
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Figure 6.3 Dopamine/caspase-3 co-expressing cells in substantia nigra. 
Separate cohorts (n= 4-6 per group) of 7-day- old, littermate Sprague-Dawley rat pups were 
randomly assigned to two groups: Naïve (room air) and Anaesthetics (70% nitrous oxide and 
0.75% isoflurane for 6 hrs). The substantia nigra was sessioned and slices were stained with anti-
caspase 3 antibodies together with anti-dopamine antibodies (staining dopaminergic neurons). 
The percentage of caspase 3 positive cells in dopaminergic neurons and the percentage of 
caspase 3 positive cells in other cells were calculated. 
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Figure 6.4 ChAT/caspase-3 co-expressing cells in basal forebrain 
Separate cohorts (n= 4-6 per group) of 7-day- old, littermate Sprague-Dawley rat pups were 
randomly assigned to two groups: Naïve (room air) and Anaesthetics (70% nitrous oxide and 
0.75% isoflurane for 6 hrs). The basal forebrain was sessioned and slices were stained with anti-
caspase 3 antibodies together with anti-choline acetyltransferase (ChAT) antibodies (staining 
cholinergic neurons). 
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6.4 Discussion 
The study presented herein demonstrates that clinically commonly-used general 
anaesthetics administered to rats during the rapid period of synaptogenesis can 
cause significant increase in cell apoptosis in the cingulate cortex, CA1 subarea of 
hippocampus and substantia nigra. The cells involved included glutamatergic, 
GABAergic and dopaminergic neurons. The basal forebrain which contains mainly the 
cholinergic neurons is spared from such neurotoxicity. Moreover, noxious 
stimulations can exacerbate anaesthesia-induced cell apoptosis in the cingulate 
cortex. 
 
6.4.1 The mechanisms of activation of apoptosis 
The mechanisms of activation of anaesthesia-induced neuroapoptosis remain elusive, 
though majority of general anaesthetics, i.e. nitrous oxide and isoflurane, are both 
N-methyl-D-aspartate (NMDA) subtype of the glutamate receptor antagonists and 
gamma-aminobutyric acid type A (GABAA) receptor agonists, so it is postulated that 
anaesthesia-induced GABAA receptor activation and NMDA-receptor blockade during 
a critical stage in brain development lead to increased cellular stress, which initiates 
the apoptotic cell death cascade in immature neurons (Jevtovic-Todorovic, 2005; 
Ikonomidou et al., 2001; Pohl et al., 1999; Ikonomidou, 2009). Moreover, animal 
studies have demonstrated that anaesthetic exposure is associated with a decrease 
in brain-derived neurotrophic factor (Lu et al., 2006) and severe depletion of 
synaptic proteins (Nikizad et al., 2007), which could be responsible, at least in part, 
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for putting neuronal survival at risk. A recent in vitro study has shown that isoflurane 
activates inositol 1,4,5-trisphosphate (IP3) receptors on the endoplasmic reticulum 
membrane inside cells, causing excessive calcium release, thus triggering apoptosis 
(Wei et al., 2008). Moreover, activation of proneurotrophin (proBDNF) signalling 
pathway via p75 neurotrophin receptor has also been shown to contribute to 
isoflurane-mediated neurotoxicity in mice (Head et al., 2009). Therefore, 
phenotypical differences among different neuronal cell types (i.e. relative 
differences in the expression of NMDA and GABAA receptors) and the different 
“niches” in which neurons are found (i.e. relative differences in the level of brain-
derived neurotrophic factors in different brain regions) may explain why the 
glutamatergic, GABAergic and dopaminergic but not the cholinergic neurons are 
susceptible to anaesthesia-induced neuroapoptosis. Moreover, different parts of the 
central nervous system mature at different rates (Clancy et al., 2001; Clancy et al., 
2007). It is possible that the stage of development of the basal forebrain in neonatal 
rats is not in the vulnerable period at seven days after birth and thus is spared from 
anaesthesia-induced neuroapoptosis.     
 
Moreover, noxious stimulations inevitably provoke tissue damage and inflammation. 
Various pro-inflammatory factors are identified in significant amounts in the blood 
stream shortly after the onset of tissue injury (Lenz et al., 2007). A recent in-vivo 
study using intraveneous anaesthetic, propofol, has demonstrated administration of 
the drug for greater than four hours was associated with a significant elevation in 
the level of the pro-inflammatory cytokine, TNF-α, in the brain regions where 
increased cell apoptosis was observed. TNF-α is one of the activators of the extrinsic 
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apoptotic pathway (Pesić et al., 2009). Therefore, it is possible that anaesthetic drugs 
induce the production of pro-inflammatory markers which stimulate the extrinsic 
apoptotic cascade and that noxious stimulations may further exacerbate this cascade 
potentiating the apoptotic injury. This could be confirmed by measuring 
inflammatory factors such as TNF-α and also looking for markers the activation of 
the extrinsic apoptotic pathway such as caspase-8 in the damaged brain regions. 
However, this theory does not explain why in the present study, noxious stimulations 
alone did not induce neuroapoptosis and also why the basal forebrain was spared 
from such damage. Furthermore, the blood-brain barrier (BBB) in 7-day-old rats is 
well developed and it can exclude exogenous inflammatory proteins from entering 
the brain’s extracellular space (Saunders et al., 1999). Therefore, I speculate that 
anaesthetics, somehow, can induce the release of endogenous inflammatory factors 
from cells present in the CNS, for example from microglial cells or from neurons 
themselves leading to neuroapoptosis. However, this process only takes place in 
certain “vulnerable” brain regions such as the cingulate cortex. The endogenous 
inflammatory factors in the “vulnerable” brain regions lead to conformational 
changes in the local BBB which becomes permeable and allow extravasations of 
exogenous inflammatory factors (Abbott, 2000) further exacerbating anaesthesia-
induced neuroapoptosis.  
 
The present study demonstrated that noxious stimulations exacerbated anaesthesia-
induced neuroapoptosis in the cingulate cortex.  
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6.4.2 Potential anaesthesia-induced long-term effects   
The developing brain has a high degree of plasticity (Nudo, 2006). Additional 
divisions of progenitors in the 7-day-old rat brain should be able to compensate for 
the loss of cells due to anaesthesia-induced cell death. But a recent study which 
showed that isoflurane can impair neurogenesis supports the hypothesis that 
anaesthesia-induced cell death is likely to be irreversible and therefore it can lead to 
permanent neurocognitive deficits later on in life (Stratmann et al., 2009). The 
increased in neuronal cell death in the cingulate cortex, hippocampus and substantia 
nigra could be responsible for the observed higher incidences of learning disabilities 
in children who had multiple general anaesthesia and surgeries (Wilder et al., 2009; 
Kalkman et al., 2009). 
 
In addition, as the dopaminergic neurons degenerate in Parkinson’s disease by 
processes that are not fully understood (Forno 1996), increased dopaminergic 
neuronal cell death post 6-hour anaesthetic exposure in rats raises the concern that 
children having general anaesthesia early in age may be at higher risk of developing 
Parkinson’s disease later on in life. Moreover, the present study showed that the 
basal forebrain is spared from anaesthesia-induced neuronal cell death suggesting 
that anaesthetic exposure at an early age may not be a risk factor for developing 
Alzheimer’s disease in older age. Moreover, the sparing of basal forebrain from 
anaesthesia-induced neuronal cell death also suggests that isoflurane-induced 
decrease in the release of acetylcholine in the rat cerebral cortex (Shichino et al., 
1998) and dorsal hippocampus (Whittington and Virag, 2006) in-vivo may not be 
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caused by the degeneration of cholinergic neurons in the basal forebrain but rather a 
direct inhibitory effect of isoflurane on cholinergic neurons.  
 
Cingulate cortex is also in resting and dream function. Emotional features in dreams 
would be related to the activation of orbito-frontal cortex and anterior cingulate 
cortex. The relative hypoactivation of the prefrontal cortex would explain the 
alteration in logical reasoning, working memory, episodic memory and executive 
functions (Maquet 2004).Anaethestics may induce psychiatric disorders such as 
schizophrenia associated with hallucination. Schizophrenia is a complex 
neuropsychiatric disorder in which symptoms can be classified as either positive, 
such as delusions and hallucinations in an animal model of schizophrenia an increase 
in oxidative damage marked by an increase in lipid peroxidation, oxidative protein 
damage and a decrease in enzymatic defenses (de Oliveiral, 2009). 
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CHAPTER 7                                         
EFFECT OF DIFFERENT PRECONDITIONING ON 
NEUROAPOPTOSIS IN THE DEVELOPING BRAIN 
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7.1 Introduction 
In most situations, the onset of injury is unpredictable but in those clinical settings in 
which it can be anticipated, for example, during brain or kidney surgery, pre-emptive 
measures may be considered. It has been proposed as early as 1943 that rats 
subjected to small graded amounts of injury, induced by hypoxia, acquired a 
tolerance enabling them to withstand an otherwise fatal insult (Noble 1943). 
However, it was not until 1986 that the concept of “preconditioning” was officially 
introduced into the scientific community, when Murry and colleagues demonstrated 
through a series of landmark experiments on canine hearts that, contrary to 
traditional and intuitive thinking, ischaemia is not always harmful (Murry et al., 
1986). They showed that pre-treatment of the heart with repeated brief episodes of 
ischaemia interwoven with reperfusion protected the myocardium from a 
subsequent, prolonged ischaemic insult and reduced the size of myocardial infarct by 
as much as 75 % compared to controls (Murry et al., 1986). In the 20 years since its 
first discovery, Murry’s seminal paper is currently the most cited article published by 
Circulation, and a Pubmed search reveals that there are, to date, in excess of 2000 
publications directly attributed to the profound effects of preconditioning. 
Interestingly, Murry and colleagues's studies overshadowed the work by Schurr, 
which was published in the same year as theirs, demonstrating the adaptation of 
adult rat hippocampal slices to anoxia by preconditioning it to hypoxia (Schurr et al., 
1986). Since then, the protective effect of preconditioning has been demonstrated in 
all organs; the first demonstration of cerebral ischaemic preconditioning against 
ischaemic injury was shown by Kitagawa (Kitagawa et al., 1990).  
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In rodents, synaptogenesis is predominantly a post-natal event, and is most intense 
just prior to birth and in the first two weeks postnatal weeks. In humans, 
synaptogenesis begins at 6 months’ gestation and ends a few years after birth. I 
sought to determine whether the anaesthetic-induced neurotoxicity could be 
attenuated by preconditioning. I sought to determine whether preconditioning 
strategies can be effective against anesthetic-induced neurotoxicity.  Ischaemia has 
been used as the stimulus in most studies of preconditioning, however, other 
interventions can also stimulate preconditioning, for example, hyperoxia, oxidative 
stress, hyperthermia, heat shock and anaesthetics including xenon. 
 
At mean time cerebral hypoxia or ischeamia have shown that neuronal death may 
occur via necrosis or apoptosis. For example, following hypoxia or ischemia, 
excitatory amino acid release and alterations in ionic homeostasis contribute to both 
necrotic and apoptotic neuronal death. However, apoptosis is distinguished from 
necrosis in that gene activation is the predominant mechanism regulating cell 
survival. Following hypoxic or ischeamic episodes in the brain, genes that promote as 
well as inhibit apoptosis are activated (Banasiak et al., 2000).  
 
I postulated that preconditioning may protect the brain of neonatal rats from 
anaesthetic drug induced apoptosis.   
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7.2 Method 
7.2.1 Animals 
Postnatal day 7 (PND7) Sprague-Dawley (SD) rat pups (Harlan UK) were used for in 
vivo, in vitro and behavioural experiments. They were housed in a 12-hour-light/12-
hour-dark schedule, with temperature (24°C) and humidity (23%) controlled 
conditions and had access to food and water ad libitum. The data of the birth was 
defined as day 0. On PND 7 which is the period of synatogenesis (Clancy et al., 2001), 
pups were used for experiments. 
 
7.2.2 In vivo 
Seven day old Sprague Dawley rat pups were pre-treated with one of the following: 
70% xenon, 70% N2O, 8% oxygen (hypoxia). They were then exposed to the 
anaesthetic combination of 70% N2O + 0.75 % isoflurane for 6h (Table 3).  The rats 
were sacrificed after anaesthesia, and their brains processed to assess the severity of 
apoptosis, caspase 3 as a marker. Brain slices and brain tissue was collected, 
immunostaining and westernblot was performed to measure the apoptosis.  
Naїve
Xe (70%) 2 hours
N2O (70%)2hours
O2 (8%) 3 hours
N2O(70%)+ISO(0.7
5%) 6 hours
24hours
 
Table 3. Seven day old Sprague-Dawley rats were exposed to different conditions presented 
above. 
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7.2.3 Preconditioning with hypoxic ischaemia 
Seven day old Sprague Dawley rat pups were pre-treated with, 8% oxygen (hypoxia) 
or ischaemia by ligating the right carotid artery. They were then exposed to the 
anaesthetic combination of 70% N2O +0.75% isoflurane for 6h (Table 4). The brains 
were removed immediately after anaesthetic exposure and sectioned for Cresyl 
Violet (Nissl) Staining. 
Naї ve
Right Carotid Artery Ligation
O2 (8%) 3hours
24hours
Hypoxic-ischemia 
Injury
 
Table 4. Seven day old Sprague-Dawley rats were exposed to different conditions presented 
above. 
 
 
7.2.4 Western blotting 
The supernatant was further centrifuged twice, initially at 11,000g for 20minutes at 
4°C for western blotting of Bcl-2 and cleaved caspase-3, and a second time at 
20,000g for 45 minutes at 4°C to separate cytosolic and mitochondrial material for 
western blotting of cytosolic cytochrome C. The membrane was probed with primary 
antibodies for Bcl-2, cleaved caspase-3 (Cell Signaling Technology, Inc, USA), 
cytochrome C (BD Biosciences Pharmingen, Oxford, UK), P53, and MAPK (Cell 
Signaling Technology, Inc, USA), followed by relevant species-derived horseradish 
peroxidise-conjugated secondary antibody for 1 hour at room temperature. 
Thereafter, the membrane was re-probed with housekeeping protein α-tubulin 
antibody (Sigma, Poole, UK).  
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7.2.5 Caspase-3 Immunohistochemistry 
Photomicrographs were taken of the whole hemisphere and hippocampus for in vivo 
and  of the hippocampus CA area for in vitro experiments with a BX-60 light 
microscope (Olympus, Southall, United Kingdom) and Axiocam digital camera (Zeiss, 
Göttingen, Germany). The images were then printed and an investigator blinded to 
the experimental protocol counted the number of DAB stained (black) cell bodies in 
the desired areas. Counting was performed on slices from the cortex and the 
hippocampus for in vivo experiments and from the hippocampal CA1-CA3 subregions 
for in vitro experiments.  
 
7.2.6 Cognitive function assessment   
Cognitive assessment was performed in separate cohort of animals 40 days after 
anesthetic exposure. The conditioning chamber (30 cm × 24 cm × 21 cm; Med 
Associates, Inc., St. Albans, VT) had a white opaque back wall, aluminium sidewalls, 
and a clear polycarbonate front door. The conditioning box had a removable grid 
floor and waste pan. Between each rat, the box was cleaned with an almond-scented 
solution and dried thoroughly. The grid floor contained 36 stainless steel rods 
(diameter, 3 mm) spaced 8 mm center to center, which made contact with a circuit 
board through which a scrambled shock was delivered. During training and context 
testing, a standard high efficiency particulate air filter (HEPA) provided a background 
noise of 65 db. On day 1 (41 days after anesthetic exposure) (Acquisition), all animals 
received 6 cycles of 214 s (seconds) of trace fear conditioning paradigm. The tone 
was presented for 16 s (2 kHz) followed by a trace interval of 18 s and subsequent 
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foot shock (2 s, 0.85 mA). The rats were removed from the conditioning chamber 
198 s after the last shock and returned to their home cage. The total time of the 
acquisition protocol was 26 min，working memory during acquisition was defined as 
the time spent immobile after a shock divided by the inter-trial interval.  
 
On the next day, (Context Test) trained rats were placed for 8 minutes to the same 
acquisition environment but without Unconditional Stimulus (the foot shock) or 
Conditional Stimulus (the tone). The percentage of time an animal froze during the 
8-min observation periods was calculated as the number of observations judged to 
be freezing divided by the total number of observations in 8 min (i.e., 60 
observations).  
On the third day, the Tone Test was performed. Rats were placed in modified 
environment (increased lighting; flat floor; and triangular side walls were inserted; 
along with a cinnamon-scented solution) where they were allowed to acclimatize for 
192 seconds before being presented to 3 cycles of a 16 sec. tone followed by a inter-
trial interval of 240 sec Freezing time automatically score using VideoFreeze 
software (Med Associates Inc., Burlington, VT). The overall percentage of freezing 
time (context results) and the area under curve (tone test) were derived from plots 
between the percentage of freezing time and trial time in the tone test and were 
used for statistical comparison.  
 
The overall percentage of freezing time was used to assess hippocampal memory 
during the context test; while for the Tone Test the area under curve (AUC) after 
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tone presentation was derived from the graph which plotted the percentage freezing 
time against trial time. 
 
7.2.7 Anaesthetics exposure in vitro study 
Following hippocampus slice incubation, the slice were assigned to one of eight 
treatments groups (Table 8) and placed in air-tight chambers (Figure 7.1). 
Naїve 
Xenon (70%) 2 hours 
N2O (70%)2hours 
O2 (8%) 3 hours 
Normal air after 24hours 70%N2O+ 0.75%ISO 6hours 
70%Xenon 2hours after 24hours 70%N2O+0.75%ISO 6hours 
70%N2O 2hours after 24hours 70%N2O+ 0.75%ISO 6hours 
8%O2 3hours after 24hours 70%N2O+ 0.75%ISO 6hours 
 
Table 4. Following hippocampus slice incubation, the slices were assigned to one of eight 
treatments groups presented above. 
                                                                                                                                                                             Yi Shu 
Imperial College London                                                     131                                                                                    Dec 2010   
 
Figure 7.1 Air-tight chambers used for treatment of hippocampus slice. 
 
 
The remaining gaseous constituents were 5% carbon dioxide, 20% oxygen and a 
variable concentration of nitrogen except during hypoxia treatment (All gases 
supplies by BOC, UK). 
The gases were delivered by a standard anaesthetic machine through the chambers 
at 2-3L/min. The gases were analysed using an S/5 spirometry module (Datex-
Ohmeda, Bradford, UK) and xenon was monitored using a 439XE monitor (Air 
Products, UK) due to xenon’s inert chemical characteristics. After 3 minutes of gas 
flow the chambers were sealed and placed in a 37°C. (Galaxy R Carbon Dioxide 
Chamber, Wolf Laboratories) 
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7.3 Results 
 7.3.1 Infarction in neonatal induced by hypoxic-ischaemia in vivo 
There wasn’t any infarction in the brain in naïve control (Figure 7.2 A). Hypoxic-
ischemia injury produced infarction in the brain (223.8 ± 20) (Figure 7.2 B). Both 
hypoxia preconditioning (6.2 ± 1.3; p<0.01) (Figure 7.2 C) and ischemia 
preconditioning (6.8 ± 0.5; p<0.01) protected the brain from the hypoxic-ischaemic 
insult and reduced the size of infarction (223.8 ± 20) (Figure 7.2). 
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Figure 7.2 Protection of hypoxia, ischemia preconditioning in hypoxic-ischemia injury in 7 days 
rat. 
(A)Percentage of infarction size of brain from bregma 2 till -5 ;( B) Average under curve of derives 
from (A). Mean ± SD, n = 3-6. **p < 0.001 (C) The data of the area under curve (AUC) derived 
from Figure B. Mean ± SD, n = 3-6. *p < 0.05 vs HI. 
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7.3.2 Neuronal apoptosis induced by anaesthetics in vivo 
There were some casapse 3 positive cells in the cortex in the naïve control (Figure 
7.3 A). However, the combined administration of N2O and ISO, (N2O + ISO), produced 
a significant increase in number of caspase 3 positive cells (Figure 7.3 B).  Xenon 
preconditioning significantly decreased the number of caspase 3 cells induced by the 
administration of the combination of N2O + ISO (Figure 7.3 C); N2O preconditioning 
did not have any significant effect (figure 7.3 D). In contrast, hypoxic preconditioning 
significantly enhanced the cellular apoptosis induced by the combination of N2O and 
ISO (Figure 7.3 E). The preconditioning regimens had no significant effect on baseline 
cellular apotosis (Figure 7.3 F). Quantitative data analysis of the 
immunohistochemically-stained brain slices, showed that hypoxic preconditioning of 
the rats followed by exposure to N2O + ISO produced a significant increase in 
number of caspase 3 positive cells in the cortex to 220 ± 22 from 177 ± 18 as 
observed in the group receiving combination of N2O + ISO only (p < 0.05). Xenon 
preconditioning significantly decreased it to 61 ± 6 (p < 0.01) whilst N2O 
preconditioning produced no significant change. Similar pattern of change in cellular 
apoptosis was found in the hippocampus (Figure 7.3 G). These findings were also 
confirmed by western blot analysis (Figure 7.4).  
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Figure 7.3. Caspase 3 positive cells in the cortex and hippocampus in vivo.  
An example of photomicrograph from cortex of a 7-day old rat pup which received no treatment 
(na¿ve control) (A), 70% N2O + 0.75% isoflurane (N2O+ISO) (B). And pups received 70% xenon (C), 
70% N2O (D) and 8% hypoxia (E) preconditioningfollowed by N2O+ISO. (F) Mean data of caspase 
3 postive cells in both hippocampus and cortex from pups which received no treatment (na¿ve 
control), or which were preconditioned with either 70% xenon, 70% N2O or 8% hypoxia only. (G) 
mean data of caspase 3 positive cells in both hippocampus and cortex from 7-day old rat pups 
which received N2O+ISO alone or which were preconditioned with either 70% xenon, 70% N2O or 
8% hypoxia followed by N2O+ISO. Mean ± SD, n = 5 - 6. *p < 0.05, p < 0.01 vs N2O+ISO. Bar = 
100µm.   
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7.3.3 Molecular Species  
Preconditioning with 70% xenon for 2 hours followed 24 hours later by exposure to 
N2O + ISO triggered a relative upregulation in expression of Bcl-2 (1.29 ± 0.05; p < 
0.05), measured 24 hours after the event, compared to the control which was 
treated with N2O + ISO alone. Pre-treatment with N2O (1.15 ± 0.1) followed by N2O 
+ ISO caused no significant change in expression of Bcl-2, but preconditioning with 
8% hypoxia followed by exposure to anaesthetic gas mixture caused a significant 
decrease in expression of Bcl-2, (0.7 ± 0.03), (p < 0.05) (Figure 7.5 A). Cytochrome C 
immunoreactivity was analysed by western blotting of the cytosolic fraction of 
cortical extracts of rats pups subjected to preconditioning. Pre-treatment with 8% 
hypoxia and 70% N2O caused a significant increase in the expression of cytochrome C 
to 2.23 ± 0.2 and 1.8 ± 0.1 respectively relative to the N2O + ISO control (p < 0.05 or 
0.01) (Figure 7.5 B). Xenon preconditioning caused a decrease in expression of p53 to 
0.79  ± 0.05 relative to N2O + ISO control, while hypoxic preconditioning induced a 
relative increase to (1.37 ± 0.1) (p < 0.05) and N2O preconditioning produced no 
significant change (Figure 7.5 C). There were no significant changes in MAPK 
phosphorylation following any of the above treatments (Figure 7.5 D).   
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Figure 7.4 Caspase 3 immunoblotting in cerebral cortex of rat pups after preconditioning or 
after preconditioning followed by anaesthetic exposure. 
(A) Top panel – example bands from 7-day old rat pups which received no treatment (na¿ve 
control), or preconditioning with either 70% xenon, 70% N2O or 8% hypoxia only; Bottom panel – 
mean data of immunoreactivity from pups which receivied no treatment (na¿ve control), or 
preconditioning with either 70% xenon, 70% N2O or 8% hypoxia only;   
(B) Top panel – example bands from 7-day old rat pups which received N2O+ISO alone or 
preconditioning with either 70% xenon, 70% N2O or 8% hypoxia followed by N2O+ISO; Bottom 
panel – mean data of  immunoreactivity from pups which received N2O+ISO alone or  
preconditioning with either 70% xenon, 70% N2O or 8% hypoxia followed by N2O+ISO. Mean ± SD, 
n = 4 -5. **p < 0.01 vs N2O+ISO. 
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Figure 7.5 Changes of protein immunoreactivity in pups’ cerebral cortex following 
preconditioning treatments.  
Seven-day old rat pups  received N2O+ISO alone (control) or preconditioning with either 70% 
xenon, 70% N2O or 8% hypoxia followed by N2O+ISO and their cortices were harvested for 
immunoblotting.  (A) Bcl-2; (B) Cytochrome C; (C) P53; (D) pMAPK. In each section, top panel – 
example bands; bottom panel – mean data ± SD (n = 4 - 5). *p < 0.05, **p < 0.01 vs control.   
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7.3.4 Neuronal apoptosis induced by anaesthetics in vitro 
The neuronal apoptosis seen in the in vivo experiments could have been due either 
to the indirect effect of the physiological disturbances or to the inherent effect of 
anesthetics or to both. In order to obviate the possible physiological effects, 
organotypic hippocampal slices was used. The number of caspase 3 cells was 
significantly increased to 53 ± 3 following N2O + ISO exposure from baseline level of 
29 ± 2 (p < 0.05) (Figure 7.6 A, B and F). The increase in caspase 3 cells was 
significantly reduced to 33 ± 4 by xenon preconditioning (p < 0.05) (Figure7.6 C and 
F); apoptosis was unchanged by N2O preconditioning. Remarkably, apoptosis 
produced by exposure to N2O + ISO was significantly increased by hypoxic 
preconditioning to 78 ± 7 (p < 0.05) (Figure 7.6 D, E and F).  
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Figure 7.6 Caspase 3 positive cells in the hippocampus in vitro.  
An example of photomicrograph of organotypic hippocampal slice, harvested from post-natal 
day 8 rat pups, cultured for 5 days prior to no treatment (naïve control) (A) 70% N2O + 0.75% 
isoflurane (N2O+ISO) (B) pups were treated with  70% xenon (C), 70% N2O (D) and 8% hypoxia (E) 
precondition and  followed by N2O+ISO. (F) mean data of caspase 3 positive cells in the 
hippocampus from 7 day old rat pups which received no treatment (naïve control), N2O+ISO 
alone or  preconditioning with either 70% xenon, 70% N2O or 8% hypoxia followed by N2O+ISO. 
Mean ± SD, n = 5 - 6. *p < 0.05, **p < 0.01 vs N2O+ISO. Bar = 100µm. The inserted image - a 
representative living culture was killed by exposure to glutamate (50 µM) and the image was 
enhanced with propidium iodide staining, acting as a guide to outline the hippocampal area 
being examed. 
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7.3.5 Cognitive function assessment 
Following preconditioning and exposure to anaesthetic gas mixture, cohorts of rats 
were allowed to live up to the age of 40 days for assessment of cognitive function 
using trace fear conditioning. Hypoxia preconditioning followed by N2O + ISO 
administration (11 ± 1; p < 0.05) and N2O + ISO administration alone (15 ± 2; p < 0.05) 
resulted in shorter hippocampal dependent-freezing  response time in the Context 
Test than xenon preconditioning followed by N2O + ISO treatment (24 ± 1).  The 
latter was similar to that observed in the naïve controls (27 ± 7; p > 0.05) (Figure 7.7 
A). The results of the Tone Test, mainly used to assess amygdalar function, showed 
that the AUC (arbitrary unit) was higher in the xenon preconditioned group exposed 
to N2O + ISO (243 ± 27) than in the hypoxic preconditioned group exposed to the 
neurotoxic anaesthetic combination (157 ± 25; p < 0.05) and the positive control 
group which received N2O+ISO only (200 ± 26; p < 0.05). The AUC in the xenon 
preconditioning followed by N2O+ISO group was not significantly different from that 
of the naїve group (261 ± 26) (Figure 7.7 B and C).  
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Figure 7.7 Cognitive function assessed with Trace fear conditioning. 
Seven-day old rat pups which received no treatment (naïve control), 70% N2O + 0.75% isoflurane 
(N2O+ISO), and pups which received 70% xenon (C), 70% N2O (D) and 8% hypoxia (E) 
preconditioning followed by N2O+ISO  were allowed to live up to the age of 40 days for cognitive 
function test. (A) The mean data of percentage of freezing time after context testing. (B) the 
mean data of percentage of freezing time after tone testing. (C) The average data of the area 
under curve (AUC) derived from Figure B. Mean ± SD, n = 6. *p < 0.05 vs N2O+ISO. 
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7.4 Discussion 
In this study, I observed significant increases in caspase-3 levels, both in vitro and in 
vivo, in the hippocampus and cortex of 7 day old rats exposed to 0.7% isoflurane + 
70% N2O in oxygen for 6 hours at 1 atmospheric ambient pressure compared to 
naïve control. The observed increase in caspase-3 levels is due to the direct effects 
of the anaesthetic drugs on neural tissues and not due to altered physiology in the 
neonatal rats, e.g. hypoperfusion of the brain, hypoglycaemia, because similar 
results were observed in the organotypic hippocampal slices. In both in vitro and in 
vivo studies xenon was effective at suppressing ISO + N2O induced apoptosis and 
subsequent deterioration in cognitive function. Conversely, hypoxic preconditioning, 
which provided a neuroprotection against ischaemic brain injury demonstrated here, 
exacerbated apoptotic neurodegeneration and worsened cognitive impairment in 
the rats when they reached adulthood.    
 
The mechanism responsible for the increase in caspase-3 levels in the developing 
brain during synaptogenesis following exposure to anaesthetic drugs was not 
directly addressed. Drugs which block NMDA receptors or promote GABAA receptor 
function have been shown to produce neurodegeneration in neonatal animal 
models (Ikonomidou et al., 1999; Wang et al., 2006; Olney et al., 2000; Young et al., 
2005) GABAA and NMDA receptors and their agonists play a fundamental role during 
synaptogenesis as they are essential for migration of neurons to the appropriate 
regions of the nervous system, dendritic filopodia stabilisation, synaptic 
development and stabilisation (Ben-Ari et al., 2007).  
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In this study, I investigated the therapeutic potential of preconditioning to prevent 
neuronal apoptosis produced by anaesthetic drugs during synaptogenesis. The 
protective effect of preconditioning with xenon against ISO + N2O induced neuronal 
apoptosis in neonatal rats could be partly attributed to the drug inhibiting 
mitochondria-induced activation of caspase-3 pathway as xenon up-regulated 
expression of anti-apoptotic Bcl-2, and down regulated pro-apoptotic tumour 
suppressor transcription factor P53. These were associated with no significant 
change in cytochrome C level. Xenon preconditioning also caused an increase in 
phosphorylation of CREB transcription factor and BDNF expression. In contrast to 
xenon preconditioning, hypoxic preconditioning exacerbated ISO + N2O induced 
neuronal apoptosis by decreasing the expression of anti-apoptotic factor Bcl-2 and 
increasing the expression of pro-apoptotic transcription factor p53  resulting in an 
increase in cytochrome C release from mitochondria.  
 
It was noted in our study that N2O increased both Bcl-2 and cytochrome C. This may 
be one of the reasons why N2O failed to induce a preconditioning state and also 
failed to protect anesthetics-induced neurotoxicity although like xenon, N2O is also 
an NMDA receptor antagonist.  Interestingly, my result is in keeping with a previous 
study in rats, which showed that preconditioning with nitrous oxide failed to reduce 
the extent of myocardial infarction following 25 minutes of coronary occlusion 
(Weber et al., 2005). 
 
Results from trace fear conditioning testing are in line with previous reports of 
cognitive impairment in rats after exposure to general anaesthesia during the 
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neonatal period (Jevtovic-Todorovic et al., 2003; Fredriksson et al., 2007; Robert et 
al., 2009). While the frontal cortex, hippocampus, periaqueductal gray, and rostral 
ventral medulla mainly underlies the acquisition of fear memories, hippocampal 
damage is causally linked to long-term memory deficit (Quinn et al., 2005). Our data 
showed that rats preconditioned with either nitrous oxide or hypoxia displayed less 
freezing compared to naïve controls and xenon preconditioned animals, indicating 
that the rodents in the first two groups suffered from long-term memory deficit 
compatible with damage to hippocampus. Indeed, this was confirmed in this study 
where we showed increased apoptosis in the hippocampus of rats which were 
preconditioned with either hypoxia or N2O and then exposed to ISO + N2O 
anaesthetics.  
 
The relevance to the human species of the above experimental findings in neonatal 
rats, and of those in many other studies conducted in neonatal animals is being 
questioned (Loepke and Soriano SG, 2008). The main argument is the lack of strong 
evidence of its toxicity in neonatal humans. However, Wilder and colleagues in a 
retrospective study of the medical and educational records of children in Olmsted 
county, showed, using multivariate analysis, that children who had repeated general 
anaesthetics before the age of 4 years had higher incidence of learning difficulties 
compared to those who received only one general anaesthetic or no anaesthetic 
(Wilder et al., 2009). In another retrospective study, Kalman and colleagues showed 
that children under 24 months undergoing urological procedures under general 
anaesthesia tended to show more behavioural problems than those operated after 
24 months of age under general anaesthesia (Kalkman et al., 2009). 
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My experimental model showed that firstly hypoxia preconditioning with hypoxic-
ischeamia injury protect the hypoxic-ischaemia infarction but period of hypoxia 
followed soon afterwards by general anaesthesia with an inhalational agent and 
nitrous oxide during the neonatal period, resulted in neuronal death and subsequent 
cognitive impairment. This indicates least but not last that hypoxia preconditioning 
working on hypoxic-ischeamia induced brain infarction and anaethestics induced 
apoptosis in different way. This unexpected finding may have important clinical 
implications. For example, neonates born with transposition of great vessels are 
hypoxic shortly after birth; they require urgent surgery to allow oxygenated blood 
from the pulmonary circulation to reach the systemic circulation. Babies born with 
gastroschisis or severe exomphalos also require urgent surgery to repair the 
abdominal defect. If they are unfortunate enough to experience foetal distress 
during child birth, they may be at increased risk of brain injury following surgical 
correction during anesthesia with the offending agents. If this finding can be 
extrapolated to clinical practice, then paediatric anaesthesiologists dealing with 
similar situations need to carefully choose anaesthetic regimen to minimise or even 
prevent brain injury.  
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CHAPTER 8                                   
NEURONAL APOPTOSIS INDUCED BY 
ANAESTHETICS IN THE PRESENCE OF NOCICEPTIVE 
STIMULI 
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8.1 Introduction 
The initial finding that N-methyl-D-Aspartate (NMDA) antagonists induce apoptosis 
in the neonatal rodent brain (Ikonomidou et al., 1999) has been rapidly succeeded 
by reports demonstrating that a diverse range of anesthetics may induce similar 
injury (Sander et al., 2008; Patel et al., 2009). Anaesthetic induced 
neurodegeneration also occurs in the monkey brain indicating that other primates, 
including humans, may be vulnerable (Slikker et al., 2007; Sanders et al., 2008; 
Brambrink et al., 2010). The injury is not due to disruption of systemic physiology 
though it occurs in a dose and duration dependent manner and combinations of 
agents produce augmented injury (Sanders et al., 2008). Furthermore the injury is 
associated with long-term impairments in cognitive function (Jevtovic-Todorovic et 
al., 2003a; Sanders et al., 2009), however the available evidence suggests that motor 
and nociceptive systems are not affected (Sanders et al., 2008). Anaesthetics induce 
widespread neuronal damage occurs in the central nervous system including the 
cerebral cortex, hippocampus, thalamus, striatum and spinal cord involving both the 
intrinsic and extrinsic caspase pathways (Jevtovic-Todorovic et al., 2003a; Yon et al., 
2005; Lu et al., 2006; Ma et al., 2007; Sanders et al., 2008; Sanders et al., 2008; 
Sanders et al., 2009a; Sanders et al., 2009b).  
 
Most general anaesthetics, including isoflurane and nitrous oxide, act on both 
NMDA receptors and gamma-aminobutyric acid type A (GABAA) receptors and it has 
been suggested that these drugs induce neuronal apoptosis via these receptors 
(Ikonomidou et al., 1999; Young et al., 2005; Slikker et al., 2007; Sanders et al., 
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2009a; Sanders et al., 2009b; Satomoto et al., 2009). Preliminary evidence suggests 
that the GABAA receptor is not responsible for this injury, at least in vitro (Sanders et 
al 2009b). On the contrary NMDA receptor antagonism may block the neurotrophic 
effects of synaptic signalling and thus may prevent inactivation of crucial mediators 
in the intrinsic apoptotic pathway such as BAD (Hardingham et al., 2009; Leveille et 
al., 2010) or activate death-signaling pathways including that mediated by the p75 
neurotrophin receptor (Head et al., 2009). 
 
Recently administration of the intravenous anaesthetic, propofol, to neonatal rats 
was shown to cause significant elevations in the pro-inflammatory cytokine, tumor 
necrosis factor (TNF)-α, in the brain regions where increased cellular apoptosis 
occurred (Pesic et al., 2009). TNF-α triggers the extrinsic apoptotic pathway though 
Fas activation, therefore it is possible that anaesthetics induce pro-inflammatory 
cytokines to stimulate the extrinsic apoptotic cascade (Pesic et al., 2009).  
 
Understanding the mechanisms involved in anaesthetic induced neurodegeneration 
is important (i) to design safe anaesthetic regimens for clinical practice and (ii) to 
understand the interaction of anaesthetics with other deleterious stimuli. For 
example I have recently reported that hypoxic preconditioning worsens the 
anaesthetic injury (Shu et al., 2010). Perhaps an even more important consideration 
is the effect that surgical stimulation may have on the injury (Sanders et al., 2008; 
Sanders et al., 2009c). Surgery inevitably activates the pain pathways and also the 
tissue injury produced can trigger further neurotoxicity through inflammatory 
mechanisms. Alternatively neuronal stimulation may oppose the apoptotic injury by 
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preventing synaptic deprivation and loss of neurotrophic effect at the synaptic level. 
In the present study, the dorsal horn of the spinal cord, thalamus, hippocampus and 
cerebral cortex of 7-day-old rats were examined after 6-hour exposure to 0.75% 
isoflurane and 70% nitrous oxide to investigate whether anaesthetic neuroapoptosis 
is reduced or exacerbated by co-administration of nociceptive stimuli. 
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8.2 Materials and Methods 
8.2.1 In vivo experiment 
Separate cohorts (n= 5-6 per group) of 7 day-old, littermate Sprague-Dawley rat 
pups were randomly assigned to six groups: 1. Naïve (room air); 2. Anaesthetics 
alone (70% nitrous oxide and 0.75% isoflurane for 6 hrs); 3. Formalin injection alone 
(subcutaneous injection with 10 µl 5% formalin into the left hind paw); 4. 
Anaesthetics + formalin injection; 5. Surgical incision alone (1 cm midline cut to the 
left hind paw); 6. Anaesthetics + surgical incision (Table 5). The remaining gas 
constituents were 30% oxygen in groups 2-6 and balanced with nitrogen where 
necessary. Surgical incision and formalin injection were conducted 10 minutes after 
rats were exposed to 70% nitrous oxide and 0.75% isoflurane and rats in group 3 and 
group 5 were then exposed to room air rather than anaesthetic reagents for 6 hours. 
In group 1, naïve rats were placed in exposure chambers for 6 hr without exposure 
to anaesthetic reagents or noxious stimuli but otherwise identical conditions as 
animals in groups 2-6. 
 
Naїve 
N2O(70%)+ISO(0.75%) 6 hours 
Formalin Injection (5%) 
Surgery Incision 
N2O(70%)+ISO(0.75%) 6 hours+ Formalin Injection(5%) 
N2O(70%)+ISO(0.75%)+Surgery Incision 
 
Table 5. Separate cohorts (n= 4 per group) of 7-day- old, littermate Sprague-Dawley rat pups 
were randomly assigned to six groups presented above. 
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8.2.2 Western blot  
 The membrane was probed with primary antibodies for IL-beta or TNF-α (Cell 
Signaling Technology, Inc, USA), others please see Chapter 3.  
 
8.3 Results   
8.3.1 Caspase 3 expression in the cortex, hippocampus, thalamus and 
spinal cord  
Relative to naïve neonatal rats, anaesthesia increased the number of caspase-3 
positive neurons in the cortex (12  ± 3 vs. 173  ± 24; p < 0.05; Figure 8.1), 
hippocampus (9 ± 3 vs. 51  ± 7; p < 0.05; Figure 8.2), and spinal cord (22  ± 5 vs. 5  ± 1; 
p < 0.05; Figure 8.3). The similar patterns of changes were found in the thalamus 
(data not shown). Interestingly formalin (cortex: 45 ± 5, hippocampus 37 ± 6, spinal 
cord: 15 ± 3; p < 0.05 vs naïve) but not surgical incision (cortex: 11 ± 5, hippocampus 
8 ± 2, spinal cord: 5 ± 2; p > 0.05 vs naïve) increased the number of apoptotic 
neurons in all three areas of the central nervous system relative to naïve mice. The 
combination of anaesthesia plus formalin and anesthesia plus surgical incision both 
increased the number of caspase-3 positive neurons in the cortex, hippocampus and 
spinal cord relative to naïve, formalin and incision groups (p < 0.05 – p < 0.01 for all). 
The number of apoptotic neurons in the anaesthesia plus formalin (cortex: 282 ± 25, 
hippocampus 96 ± 13, spinal cord: 43 ± 5) did not differ from anaesthesia plus 
surgical incision (cortex: 242 ± 41, hippocampus 78 ± 10, spinal cord: 38 ± 5). 
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Figure 8.1 Caspase 3 positive cells in the cortex.  
Seven old rat pups received 70% N2O + 0.75% isoflurane anaesthesia with or without the plantar 
surface of left paw injection with 5% formalin or skin incision for 6 hrs. Other cohorts received six 
hours of 70% nitrogen balanced with oxygen (naïve control), or combined with left paw plantar 
surface injection of 5% formalin (formalin group) or skin incision (incision group). An example of 
photomicrograph from cortex of a 7-day old rat pup which received no treatment (na¿ve control) 
(A), 70% N2O + 0.75% isoflurane (anaesthesia) (B), formalin injection (C), skin incision (D), 
formalin injection + anesthesia (E) and skin incision + anaesthesia (F). (G) Mean data of caspase 3 
postive cells in cortex from pups which received the treatments described above. Mean ± SD, n = 
5 - 6. ** p < 0.01 vs Naïve;  +p < 0.05, ++ p < 0.01 vs anaesthesia. Bar = 100µm.   
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Figure 8.2 Caspase 3 positive cells in the hippocampus.  
Seven old rat pups received 70% N2O + 0.75% isoflurane anaesthesia with or without the plantar 
surface of left paw injection with 5% formalin or skin incision for 6 hrs. Other cohorts received six 
hours of 70% nitrogen balanced with oxygen (naïve control), or combined with left paw plantar 
surface injection of 5% formalin (formalin group) or skin incision (incision group). An example of 
photomicrograph from cortex of a 7-day old rat pup which received no treatment (naïve control) 
(A), 70% N2O + 0.75% isoflurane (anaesthesia) (B), formalin injection (C), skin incision (D), 
formalin injection + anaesthesia (E) and skin incision + anaesthesia (F). (G) Mean data of caspase 
3 postive cells in cortex from pups which received the treatments described above. Mean ± SD, n 
= 5 - 6. ** p < 0.01 vs Naïve;  ++ p < 0.01 vs anaesthesia. Bar = 100µm.   
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Figure 8.3 Caspase 3 positive cells in the lumbar level of the spinal cord.  
Seven old rat pups received 70% N2O + 0.75% isoflurane anaesthesia with or without the plantar 
surface of left paw injection with 5% formalin or skin incision for 6 hrs. Other cohorts received six 
hours of 70% nitrogen balanced with oxygen (naive control), or combined with left paw plantar 
surface injection of 5% formalin (formalin group) or skin incision (incision group). An example of 
photomicrograph from cortex of a 7-day old rat pup which received no treatment (naïve control) 
(A), 70% N2O + 0.75% isoflurane (Anaesthesia) (B), formalin injection (C), skin incision (D), 
formalin injection + anaesthesia (E) and skin incision + anaesthesia (F). (G) Mean data of caspase 
3 postive cells in cortex from pups which received the treatments described above. Mean ± SD, n 
= 5 - 6. ** p < 0.01 vs Naïve;  ++ p < 0.01 vs anaesthesia. Bar = 100µm. 
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8.3.2 C-Fos expression in the thalamus and the spinal cord 
Both nociceptive stimuli increased the number of c-Fos positive neurons in the 
thalamus (Figure 8.4) and spinal cord (Figures 8.5) relative to naïve neonatal rats (p < 
0.05 for both) consistent with activation of the spinothalamic tract. Formalin 
(thalamus: 105 ± 5, spinal cord: 68 ± 12) and incision (thalamus: 65 ± 4, spinal cord: 
53 ± 5) induced c-Fos positive neurons relative to naïve controls (thalamus: 6 ± 2, 
spinal cord: 4 ± 2). Interestingly anaesthesia plus either of the nociceptive stimuli 
induced more neuronal activation in the thalamus than in the other groups (p < 
0.05), anaesthesia plus formalin induced 201 ± 12 and anaesthesia plus incision 
induced 144 ± 15 c-Fos positive neurons in the thalamus. However anesthesia co-
administered with formalin (spinal cord: 45 ± 8) or incision (spinal cord: 34 ± 7) 
reduced c-Fos expression in the spinal cord relative to the nociceptive stimuli alone 
(Figure 8.5).  
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Figure 8.4 c-FOS positive cells in the lumbar level of the spinal cord.  
Seven old rat pups received 70% N2O + 0.75% isoflurane anaesthesia with or without the plantar 
surface of left paw injection with 5% formalin or skin incision for 6 hrs. Other cohorts received six 
hours of 70% nitrogen balanced with oxygen (naïve control), or combined with left paw plantar 
surface injection of 5% formalin (formalin group) or skin incision (incision group). An example of 
photomicrograph from cortex of a 7-day old rat pup which received no treatment (A) Naïve 
control (B)  70% N2O + 0.75% isoflurane (anaesthesia) (C) Formalin injection  (D) Skin incision  
(E)Formalin injection + anaesthesia (F)Skin incision + anaesthesia (G) Mean data of caspase 3 
postive cells in cortex from pups which received the treatments described above. Mean ± SD, n = 
5 - 6. ** p < 0.01 vs Naïve;  ++ p < 0.01 vs anaesthesia. ≠≠ p < 0.01 vs Incision. Bar = 100µm.   
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Figure 8.5 C-Fos positive cells express in thalamas.  
 Seven old rat pups received 70% N2O + 0.75% isoflurane anaesthesia with or without the plantar 
surface of left paw injection with 5% formalin or skin incision for 6 hrs. Other cohorts received six 
hours of 70% nitrogen balanced with oxygen (naïve control), or combined with left paw plantar 
surface injection of 5% formalin (formalin group) or skin incision (incision group). An example of 
photomicrograph from cortex of a 7-day old rat pup which received no treatment(A) Naïve 
control  (B)70% N2O + 0.75% isoflurane (anaesthesia) (C)Formalin injection (D)Skin incision (E) 
Formalin injection + anaesthesia (F) Skin incision + anaesthesia  (G) Mean data of caspase 3 
postive cells in cortex from pups which received the treatments described above. Mean ± SD, n = 
5 - 6. ** p < 0.01 vs Naïve;  ++ p < 0.01 vs anesthesia. ≠≠ p < 0.01 vs Incision. Bar = 100µm.   
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8.3.3 Cytokine expression in the cortex 
In order to understand whether cortical inflammatory changes correlated with 
increased cortical apoptosis we performed western blot for IL-1ß and TNF-α. Six 
hours after the start of the treatments anaesthesia plus the nociceptive stimuli 
increased IL-1ß but not TNF- α level compared to controls (Figure 8.6). 
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Figure 8.6 Changes of proinflammatory cytokines of IL-1ß or TNF-α protein immunoreactivity in 
pups’ cerebral cortex.  
 Seven old rat pups received 70% N2O + 0.75% isoflurane anaesthesia with or without the plantar 
surface of left paw injection with 5% formalin or skin incision for 6 hrs. Other cohorts received six 
hours of 70% nitrogen balanced with oxygen (naïve control), or combined with left paw plantar 
surface injection of 5% formalin (formalin group) or skin incision (incision group). (A) IL-1ß; (B) 
TNF-α.  In each section, top panel – example bands; bottom panel. Mean data ± SD (n = 5). **p < 
0.01 vs Naïve control. 
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8.3.4 Cognitive function changes 
Forty days after the initial treatment (on post natal day 7) cognitive function was 
assessed with Trace fear conditioning (Figure 8.7). Consistent with impaired 
cognitive function, anaesthesia and anaesthesia plus the nociceptive stimuli both 
reduced the mean percentage freezing time after context testing compared to naïve 
rat pups (p < 0.05). Tone testing revealed that combining the nociceptive stimuli 
with anaesthesia induced a long-term detriment in cognitive function that was 
significantly greater than that induced by anesthesia alone. The area under the curve 
data showed that whilst anaesthesia decreased freezing time in the tone test (p < 
0.05 vs. naïve) anaesthesia plus formalin and anaesthesia plus incision both 
decreased freezing even further (p < 0.05 vs. other groups). 
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Figure 8.7 Cognitive function assessed with Trace fear conditioning.  
Seven old rat pups received 70% N2O + 0.75% isoflurane anaesthesia with or without the plantar 
surface of left paw injection with 5% formalin or skin incision for 6 hrs. Other cohorts received six 
hours of 70% nitrogen balanced with oxygen (naïve control), or combined with left paw plantar 
surface injection of 5% formalin (formalin group) or skin incision (incision group). They were then 
allowed to live up to the age of 40 days for cognitive function test. (A) The mean data of 
percentage of freezing time after context testing. (B) The mean data of percentage of freezing 
time after tone testing. (C) The average data of the area under curve (AUC) derived from Figure B. 
Mean ± SD, n = 6. **p < 0.05 vs Naïve; ++ p < 0.01 vs Anaesthesia.  
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8.4 Discussion 
I have shown that administration of nitrous oxide and isoflurane to 7 day old rats 
produces widespread neuroapoptosis in the cerebral cortex (Figure 8.1), 
hippocampus (Figure 8.2) and spinal cord (Figure 8.3) consistent with previous 
studies (Jevtovic-Todorovic et al., 2003a; Ma et al., 2007; Sanders et al., 2008; 
Sanders et al., 2008; Sanders et al., 2009b; Sanders et al., 2009c; Satomoto et al., 
2009) and the production of long-term cognitive impairment (Figure 8.7; (Jevtovic-
Todorovic et al., 2003a; Sanders et al., 2009b). Furthermore formalin, but not 
surgical incision, inflicted after a very short anaesthetic administration (i.e. one that 
does not produce injury) produced a significant increase in caspase-3 positive cells in 
all areas of CNS studied compared to naive rats but neither stimulus produced 
cognitive dysfunction. More importantly, I demonstrated that nociception induced 
by formalin and surgical incision during anaesthesia augmented the number of 
caspase-3 positive cells and produced more long-term cognitive impairment 
compared to anaesthesia alone (Figures 8.1-3 and 8.7). That surgery may exacerbate 
the injury to the central nervous system produced by anaesthetic drugs during 
general anaesthesia is significant as it is very relevant to clinical practice and it 
cannot be ignored.  
 
8.4.1 Mechanisms of Anaesthesia-Induced Apoptosis 
Several mechanisms have been postulated for anaesthetic drug induced neuronal 
apoptosis in rodents or primates during the period of synaptogenesis though a role 
for synaptic deprivation appears to be the most likely explanation (Ma et al., 2007; 
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Head et al., 2009; Pesic et al., 2009).  Recently Head and colleagues showed that 
isoflurane reduced the release of tissue plasminogen activator (which is dependent 
on neuronal activity) into the synaptic cleft; this lead to activation of the p75 
neurotrophin receptor and neuronal apoptosis (Head et al., 2009). GABAA and 
NMDA receptors and their agonists are essential for synaptogenesis and for control 
neuronal activation (Ben-Ari et al., 2007). During this period, depolarisation of cells 
in the developing nervous system is produced primarily by GABA (Ben-Ari et al., 
2007). Immature neurons have higher intracellular chloride ion concentration 
relative to the extracellular environment than in mature neurons; stimulation of 
GABAA receptors, therefore, produces efflux of chloride ions causing neuronal 
depolarisation (Ben-Ari et al., 2007). As central nervous system mature NMDA 
receptor population increases and it becoming the predominant excitatory receptor. 
We suspect that the anaesthetic neurotoxicity is not secondary to activation of 
GABAA receptors as (i) this would not reduce neuronal activation (Ben-Ari et al., 
2007) and (ii) the injury is not blocked by the GABAA antagonist, gabazine (Sanders 
et al., 2009b). The most plausible cell surface receptor target for the injury therefore 
remains blockade of the NMDA receptor and stimulation of the intrinsic apoptotic 
pathway (Hardingham et al., 2009; Head et al., 2009; Leveille et al., 2010). Other 
receptor targets including potassium channels, which contribute to neuronal 
hyperpolarisation and neuronal apoptosis (including TASK channels may also play a 
role (Patel et al., 2004)). 
 
The description of noxious stimuli inducing apoptosis in the neonatal brain is not 
new; previous studies administered repeated formalin injections between post-natal 
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days 1 and 4 and suggested the injury may be excitotoxic in nature with a distinct 
role for glial cell activation (Anand et al., 2007; Rovnaghi et al., 2008). In the adult, 
repeated formalin injections induce spinal cord apoptosis (Jalalvand et al., 2008) but 
a distinct role for pain-induced apoptosis is now noted in the neonate with only one 
dose of formalin (Figures 8.1-3). Subcutaneous formalin administration into rat’s 
hind paw is a well-established inflammatory pain model (Ma et al., 2004; Anand et 
al., 2007). It produces a mixed inflammatory, tissue and nerve injury resulting in 
peripheral and central pain sensitisation; while it is possible that inflammation plays 
a role in producing the formalin-induced neuronal injury (Rovnaghi et al., 2008), I did 
observe changes in cortical IL-1ß but not TNF-α (Figure 8.6).  Surgical incision also 
produces peripheral and central sensitisation however the duration of the insult is 
shorter (Zahn et al., 2002) and inflammation plays a less prominent role (Zahn et al., 
2004). Indeed both form of nociceptive stimuli induced c-Fos in the dorsal horn of 
the spinal cord and thalamus (Figure 8.4 and 8.5) indicating activation of the 
spinothalamic tract.  
 
At present the mechanism of formalin-induced apoptotic injury is unclear though 
the mechanism of pain clearly differs from that induced by incision due to (i) 
duration (Zahn et al., 2002), (ii) intensity (Zahn et al., 2002) and (iii) mechanism 
(Watkins et al., 1997; Zahn et al., 2002). Future studies directed at probing the 
differences between the ability of formalin and incision to induce apoptosis should 
focus on the role of the p75 neurotrophin system in producing apoptosis as 
neurotrophins play an important role in the pain pathway (Pezet and McMahon 
2006). Nonetheless the role of inflammation should not be dismissed (Head et al., 
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2009). However it is important to note that single administration of either 
nociceptive stimulus did not induce cognitive dysfunction (Figure 8.7), unlike the 
administration of multiple doses of formalin (Anand et al., 2007; Rovnaghi et al., 
2008). 
 
It is of interest that anaesthesia further activated c-Fos at the level of the thalamus 
compared to the nociceptive stimuli (Figure 8.4); we suspect that this may relate to 
nitrous oxide-induced activation of neuronal signalling in supraspinal centers 
(Sawamura et al., 2000; Sawamura et al., 2003). In the spinal cord, anaesthesia 
reduced the nociception-induced c-Fos expression (Figure 8.5) consistent with the 
known antinociceptive effect of isoflurane (Sanders et al., 2005). Importantly both 
forms of nociceptive stimuli exacerbated the anaesthetic injury. 
 
8.4.2 Mechanisms of Nociception plus Anaesthesia-Induced Apoptosis 
I don’t think the mechanisms of nociceptive stimuli can increase apoptosis since 
animals are anaesthetised by pain memory because though the dose of anaesthetics 
I used is under 1 MAC,during 6 hours the animals were fully anae, and the animals 
were sacrificed immediately after gas expouse.The exacerbation of the anaesthetic 
injury by noxious stimulation may have occurred secondary to an inflammatory 
response that stimulated the extrinsic apoptotic pathway via inflammatory cytokine 
production (Figure 8.6) with downstream caspase-3 activation (Figure 8.1). It is 
clearly of interest that TNF-α level did not differ from controls and I only observed 
changes in IL-1ß (Figure 8.6). This may be due to the sensitivity of my assay or due to 
the sampling interval, as I only chose one time point we may have missed the peak 
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TNF-α level. Nonetheless IL-1ß may contribute to apoptosis (Hu et al., 1997; Allan et 
al., 2001; Allan et al., 2005) and therefore remains a plausible target for 
neuroprotection (Allan et al., 2001; Allan et al., 2005). Future studies should 
examine this time course more closely as well as employ cytokine blocking 
antibodies to probe this suggested association.  
 
Herein we do not consider it likely that the nociceptive stimuli exacerbated 
anaesthetic injury through an excitotoxic mechanism as we administered a 
combination of anaesthetics that block the NMDA receptor (Franks et al., 2008) and 
therefore would be expected to prevent excitotoxicity (Hardingham 2009). A further 
possibility is that nociceptive signalling increased the availability of neurotrophins at 
the synapse but simultaneous anesthesia impaired tissue plasminogen activator 
release, directing the neurotrophin pathway towards p75 neutrophin activation and 
cell death (Head et al., 2009). Future mechanistic studies should investigate these 
possibilities. 
 
 
8.4.3 Caveats 
There are several confounds between extrapolating preclinical results to changes in 
clinical practice, including species differences, that are well known and necessitate 
that the clinical implications of a preclinical study be cautiously interpreted (Sanders 
et al., 2008). Specifically for this study anaesthesia was administered for six hours, a 
duration that is relatively uncommon in neonatal anaesthesia, although this is an 
accepted model of anaesthesia-induced neurodegeneration (that also occurs at sub-
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anaesthetic doses for administered for one hour (Johnson et al., 2008). Furthermore 
the pain stimuli that were administered do not last for six hours (Zahn et al., 2002; 
Ma et al., 2004) and therefore my study does not replicate constant surgical 
stimulation during anaesthesia however I speculate that if repeated noxious stimuli 
had been administered a greater exacerbation of anaesthetic injury may have been 
observed.  I administered a level of anaesthesia that is lower than 1 MAC in rodents; 
in clinical anaesthesia this would represent a subclinical dose. This was chosen to 
reduce the physiological consequences of anaesthesia though higher doses produce 
greater neurodegneration (Jevtovic-Todorovic et al., 2003). Nociceptive stimulation 
may therefore have greater impact in this paradigm than at deeper levels of 
anaesthetic though a counter argument that clinical surgery produces greater 
nociceptive stimulation may also be made. Future studies will concentrate on more 
closely replicating the clinical scenario with shorter, deeper anaesthesia in a 
surgically relevant model. 
Furthermore, nociception may be deemed to be a smiliar preconditioning fuction as 
hypoxia preconditioning. As discussed in Chapter 7, nociception may have similar 
mechanisms which are responsible for the hypoxic preconditioning to enhance the 
neurodegeneration induced by anaethestics.      
 
8.4.5 Potential Clinical Impact 
Our observation that nociceptive stimulation exacerbates anaesthesia induced 
apoptosis and cognitive impairment is of concern. Indeed surgical incision itself did 
not induce apoptosis or cognitive impairment yet augmented the anaesthetic injury 
on a morphological (Figures 8.1, 8.2 and 8.3) and functional level (Figure 7). The 
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incision model may be considered analogous to minor or peripheral surgery that 
occurs without visceral manipulation; it is possible that more major surgery may 
have a greater deleterious effect. Nonetheless the data suggest that the 
combination of a surgical incision and anaesthesia may produce more cognitive 
impairment than anaesthesia alone. The cognitive impairment observed, in both the 
tone and context fear conditioning tests, indicates involvement of several brain 
regions including the prefrontal cortex, hippocampus, and amygdala in the injury 
(Sanders et al., 2003).  It is of interest that when isoflurane (0.75%) is administered 
deficits are only observed in the context test (Sanders et al., 2009b) but herein we 
show that deeper anaesthesia (isoflurane 0.75% and nitrous oxide 70%) and 
anaesthesia combined with nociception produces injury in both the tone and 
context test. This is consistent with a more severe and widespread lesion with the 
latter stimuli. Indeed the anesthetic injury is known to be dose responsive 
(Ikonomidou et al., 1999; Jevtovic-Todorovic et al., 2003a; Young et al., 2005; 
Slikkers et al., 2007; Sanders et al., 2008; Sanders et al., 2009c; Sanders et al., 2009b; 
Satomoto et al., 2009; Brambrink et al., 2010) and this has also been suggested for 
nociceptive stimuli (Anand et al., 2007; Rovnaghi et al., 2008).  
 
In conclusion, I have shown that nociceptive stimuli administered during isoflurane 
and nitrous oxide anesthesia produced significantly more apoptosis in the CNS than 
anaesthesia alone. This raises serious concern that, should this observation be true 
to humans also, that surgery may exacerbate an anaesthetic injury causing 
significant CNS damage to neonates during the synaptogenic period. Potential 
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therapies to blunt the anesthetic and surgical injuries, identified through further 
mechanistic investigation, are urgently required. 
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CHAPTER 9    
CONCLUSION 
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9.1 Main findings  
Anaesthetics, 0.75% isoflurane and 70% nitrous oxide have been demonstrated to 
induce apoptotic neurodegeneration when administered during neurodevelopment. 
It activates the common apoptotic pathway and intrinsic apoptotic pathway. 
 
Anaesthetics provoke spinal cord injury in neonatal rats, increasing caspase-3 within 
the ventral horn of spinal cord. Caspase 3 expression occurs in cingulate cortex, CA1 
subarea of hippocampus, substantia nigra and basal forebrain. Furthermore 
anaesthetic exposure significantly increased the number of caspase-3 positive cells 
in the CA1 subarea of hippocampus, cingulate cortex, and substantia nigra, but not 
in the basal forebrain.  
 
Preconditioning with hypoxia or xenon had been shown to protect against 
subsequent brain injury induced by hypoxia/ischaemia in rats. These may be 
potential ways of protecting against anaesthetic drug induced neurotocity. However, 
my data show that xenon preconditioning prevented N2O + ISO induced 
neurotoxicity during neurodevelopment in both in vivo and in vitro. In contrast, 
hypoxic preconditioning exacerbated the anaesthetic-induced neurotoxicity whereas 
N2O had no effect on preconditioning. Xenon preconditioning increased Bcl-2 
expression and decreased cytochrome C release and P53 expression but the mirror 
effect on those signals was evident for hypoxic preconditioning. Furthermore, xenon 
preconditioning attenuated the deterioration in cognitive function produced by 
anaesthetics, whilst hypoxic preconditioning worsened it. It indicates that 
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inhalational anaesthesia with nitrous oxide and isoflurane to an asphyxic baby for 
emergency surgery immediately after birth may result in severe brain damage.  
 
Anaesthetics neurotoxicity in the absence surgical stimuli may be only relevant in the 
critical care setting. Therefore, the experiments carried out so far do not represent 
conditions in the operating room where neonates undergo sugery under general 
anaesthesia where both are occurring at the same time.  This study was designed to 
investigate the impact of nociceptive stimuli on anesthetic induced neuroapoptosis in 
the rat developing brain. In a model of nociceptive stimulation using formalin 
injection and surgical incision in the paw in neonatal rats, administration of 
anaesthesia caused a widespread distribution of caspase 3 positive cells in the brain 
and spinal cord, and this was significantly enhanced by the nociceptive stimuli. The 
detrimental effects of nociceptive stimuli further exacerbated the cognitive 
impairment induced by anaesthetics in these neonatal rats. Activation of the pain 
pathway as identified using labelled c-Fos was associated with neuroapoptosis 
enhancement as was the presence of IL-1β cytokine in the brain regions involved. Our 
data suggest that nociceptive stimuli produced significantly more apoptosis in the 
CNS than anaesthesia alone. This raises serious concern; should this observation be 
true to humans also, surgery may exacerbate the anaesthetic induced injury causing 
significantly more damage to the CNS in neonates during the synaptogenic period. 
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9.2 Clinical Implications 
More evidences have been demonstrated that we should choose carefully the 
anaesthetic drugs we use in critical care.  The noble anaesthetic gas xenon displays 
many of the hallmarks of the ideal anaesthetic agent; its neuroprotective potential, 
through a preconditioning phenomenon, has been demonstrated in an in vivo model 
of acute neuronal HI injury (Ma et al. 2006) and anaesthetic drugs induced injury as 
presented in this thesis. This may indicate that this anaesthetic gas may be the ideal 
anaesthetic drug for paediatric anaesthesia. 
 
Despite intensive research over several decades, there are still no satisfactory 
clinical strategies to reduce the vulnerability of brain to injury. Mitigating the 
consequences of HI/R injury with a safe, efficacious and non-toxic agent represents 
an unmet healthcare need. 
 
Xenon has been used safely in the clinical setting as an anaesthetic in patients of all 
ages for more than 50 years and its potent preconditioning properties combined 
with its powerful organ protective capabilities, could be put to a greater use in 
several fields of medicine, where there is an anticipated risk of HI or IR organ injury. 
Applications may include the use of xenon intra-operatively for procedures that 
carry a substantial risk of HI injury, such as cardiopulmonary bypass surgery, renal 
transplantation surgery or neurosurgery. Xenon may also be pre-emptively 
administered to expectant mothers in labour who have a high risk of neonatal 
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hypoxia, such as pre-term labour. In addition, it has a safety profile that is unrivalled 
(Sanders, Franks & Maze 2003). 
 
Xenon, therefore, represents a promising new therapeutic strategy for reducing the 
incidence of disorders arising through HI or IR injury. Elucidation of the organ 
protective mechanism of xenon as a preconditioner is essential if it is to progress 
and be used safely and efficaciously in the clinical setting. 
 
Until recently, the high cost and scarcity of xenon have prevented its widespread 
clinical application; with refinements in production of xenon and the advent of 
xenon-conserving ventilation systems, such as closed-loop or low-flow systems, 
financial concerns have been alleviated to a large extent. It is still probable at first, 
however, that its use will have to be reserved for high risk patients. 
 
Clinical translation of my findings will facilitate the use of xenon in preventing 
hypoxia-related injury. By understanding the mechanisms involved in xenon’s 
preconditioning, it will be possible to prioritise the clinical settings that are most 
likely to benefit from this safe and efficacious anaesthetic agent. 
 
Moreover, results from these experiments have established that xenon mediates its 
preconditioning action via its effects on the apoptotic pathway; data from these 
studies will enhance our understanding of the interactions of the putative signalling 
cascades that are involved. 
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Even if xenon itself were not to be clinically exploited, date from this study may 
facilitate the discovery and development of novel chemical entities for action at 
newly identified therapeutic targets to protect against impending injury, while 
avoiding those that may promote toxicity. 
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